ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[STARD13, TBXA2R, ROCK2, SERPINF1, SARS, TEK, THBS1, GTF2I, CCR2]
GO:0036498;IRE1-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;55.46397693329154;5.825829909099042;0.0018563293936187412;0.6210535250702663;[ZBTB17, XBP1, WFS1, EDEM1, SYVN1, ARFGAP1, YIF1A, ERN1, EXTL2, CTDSP2, LMNA, DNAJB11, TPP1, HYOU1]
GO:0000188;inactivation of MAPK activity;13.0;0.8436909121759173;0.8844004208555951;9.558319993818873;2610.871803759405;6.518977089658987;0.08738352963975493;0.7959357562962344;[PPP2CA, DUSP22, DUSP5, CAV1, GPS1, DUSP14]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[DUSP5, MAP4K2, PDE6H, THBS1, MAPK8IP3, ERN1, P2RX7, KARS, TAOK2, KIT, MADD, RIPK1, CCL19]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[PER2, SFRP1, ARL2BP, CCL5, ITPR2, ARL2, AACS, ARNTL, BAIAP3]
GO:0051882;mitochondrial depolarization;5.0;1.0;0.7902410118609202;9.628524252492122;25.75696197398942;8.67846133901236;8.620623375086068E-4;0.7340579283277371;[ATPIF1, ABL1]
GO:0000185;activation of MAPKKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;6.8867018697843045;0.12404468480698592;0.814741218652794;[MAP4K2]
GO:0000183;chromatin silencing at rDNA;12.0;1.0;0.9481203125901445;9.628524252492122;1754.5970941496832;7.292166977892469;0.058724785706324785;0.8210420709600095;[SUV39H1, H3F3A, SIRT2]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[NFKBIA, POLA2, BCL3, TNPO1, TNPO2, KPNB1, IPO4, ARNTL]
GO:2000234;positive regulation of rRNA processing;8.0;1.0;0.875;9.628524252492122;509.0927097605666;7.57984905034425;0.017038874841993235;0.7626338329336335;[HEATR1, WDR43]
GO:2000352;negative regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.9263443150347;6.444869117505266;0.0043485178181058145;0.7258315315665724;[FGA, ANGPT1, TNIP2, FGG, ABL1, TEK]
GO:0035037;sperm entry;6.0;1.0;0.8231203125901445;9.628524252492122;36.46820493409469;9.777073627680469;0.0012205579998905152;0.8231203125901445;[UBE3A]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[POLB, PIGT, CDK5, DIABLO, MAX, CASP3, BID, CIT]
GO:0050798;activated T cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;53.24038617789342;8.390779266560578;0.0017819078121373234;0.7800242071602487;[ABL1]
GO:0036123;histone H3-K9 dimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;1326.2992443831567;8.67846133901236;0.04439004211767886;0.8919372290569614;[SUV39H1]
GO:0036124;histone H3-K9 trimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;1326.076100831845;8.16763571524637;0.044382573703832605;0.8658135829017477;[SUV39H1, ARID4A]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[CDK5, FES, ABL1, TEK, HRAS]
GO:1900025;negative regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;367.370684139938;7.212124270218933;0.012295566186013157;0.7438283705770736;[RCC2]
GO:1900027;regulation of ruffle assembly;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;51.76168527241457;6.444869117505266;0.001732417023575362;0.7045909063862833;[CAV1, RCC2, FAM98A, HRAS]
GO:1902445;regulation of mitochondrial membrane permeability involved in programmed necrotic cell death;7.0;1.0;0.8509193652572005;9.628524252492122;52.52727335290614;8.67846133901236;0.001758040567644875;0.7947362817240173;[PPIF, ALKBH7]
GO:1900026;positive regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;350.51777089970517;6.280566066213989;0.011731514346499779;0.6961884407023742;[FGA, ARPC2, C1QBP, FGG, ABL1, CIB1, UNC13D, LIMS1, S100A10]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[DCLRE1A, DCLRE1C, CCNH, MUM1, CIB1, PARK7, ALKBH7, YY1, MYC, EP300, NEK1, GTSE1, AQR, TIPIN, FBXO18, NSMCE2, NEIL3, MSH3, DDIT4, TIMELESS, PAXIP1, COPS7B, COPS7A, XPC, RAD51AP1, NUAK1, CCNB1, RAD21, ABL1, USP51, FANCI, XRCC6, UBE2B, XRCC5, INTS3, NONO, CNOT10, CDC7, FANCE, SETX, CDK9, CNOT4, CNOT6, COPS5, NPLOC4, CNOT7, CNOT1, UBE2T, BCL3, CNOT3, CDK2, INTS7, CNOT8, MNAT1, USP36, FEN1, BTG2, CDKN1A, SMG1, WDR48, SUV39H1, MCM10, BRCA1, AATF, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, CASP3, CASP2, CTLA4, TOPBP1, RFC5, UPF1, RFC3, RFC4, DTX3L, RFC1, NCOA6, PARP2, RAD23A, TFIP11, MASTL, DDB1, RAD51C, TFDP1, TFDP2, PCNA, PNKP, GPS1, TANK, UNG, TFPT, FZR1, WRN, POLR2B, RBBP5, RAD54L, POLR2G, BID, E2F7, E2F8, POLQ, EYA2, GINS4, DONSON, APEX2, GTF2H4, SMUG1, HIST3H2A, RAD51, TTC5, POLE2, RFWD3, TAOK2, POLE3, MNDA, ERCC5]
GO:0006975;DNA damage induced protein phosphorylation;8.0;1.0;0.875;9.628524252492122;212.05375489921127;7.697632086000634;0.007097248340487313;0.7686572628545723;[ABL1]
GO:0006851;mitochondrial calcium ion transmembrane transport;10.0;0.8436909121759173;0.837086467948879;9.510741216835738;118.62675870594882;6.7325511899570465;0.003970330856736533;0.7595439928109722;[STOML2, PMPCB]
GO:0051895;negative regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;270.76229412472316;7.069023426578259;0.009062170314110184;0.7365101867784198;[RCC2, THBS1]
GO:0048011;neurotrophin TRK receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;58.19790639729547;6.781341354126479;0.0019478315524021762;0.7217981122146513;[CASP3, DDIT4]
GO:0005997;xylulose metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;34.319345740475256;8.390779266560578;0.0011486376165277907;0.7522251544931926;[DCXR]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP2, NCKAP1, NCF1, ROCK2, ITGB3, ELMO1, NCKAP1L, VAV1]
GO:2000009;negative regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.78875676133134;7.212124270218933;0.0024696432832320894;0.7197477358342742;[TAX1BP3, COMMD1]
GO:0051894;positive regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;280.4986055833795;6.599019797332524;0.009388035896519984;0.712474179321389;[SFRP1, ABL1, TEK, LIMS1, S100A10]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, NUP153, RGPD1, IPO4, NUP93, NCKIPSD, IPO8, IPO9, NUP62, LMNA, HEATR3, TNPO1, TNPO2, RAE1, KPNB1]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[BECN1, ERRFI1, EIF4A3, CIB1, LRP8, THBS1, RELA, CLEC3B, CCL5, RIPK1, ATP7A, SOX6, EMD, BPTF, TBX1, PDGFRB, CAV1, CAD, RUNX2, SIRT2, SETX, ERN1, VIL1, SFRP1, MARS, MT1G, LIMS1]
GO:0006607;NLS-bearing protein import into nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;278.22868408041535;6.481236761676141;0.009312063666612497;0.7466917612613706;[NCKIPSD, TNPO1, TNPO2, RGPD1, KPNB1, IPO4]
GO:2000001;regulation of DNA damage checkpoint;7.0;0.7866048967936545;0.7442218136540277;9.446202695698167;47.13716505022567;7.004484905440688;0.0015776384935366925;0.7091290490632969;[RINT1, FEM1B, RFWD3]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[PDGFRB, IGFBP5, ANGPT1, CD80, PARK7, THBS1, VAV1, STK3, MTDH, C1QBP, KIT, CCL19, TEK, MET, HBEGF]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[FLCN, CIB1, TRIB3]
GO:1900272;negative regulation of long-term synaptic potentiation;9.0;1.0;0.896240625180289;9.628524252492122;54.24497338163739;7.57984905034425;0.0018155304417768478;0.7838744581139225;[PRNP, ABL1, AGER]
GO:0036471;cellular response to glyoxal;6.0;1.0;0.8231203125901445;9.628524252492122;106.71488924729117;9.777073627680469;0.0035716513059417736;0.8231203125901445;[PARK7]
GO:0060261;positive regulation of transcription initiation from RNA polymerase II promoter;12.0;0.9326813400603323;0.9144609826203107;9.606545345773347;3603.970423346374;6.7325511899570465;0.12062164670659907;0.7924232935401965;[PAXIP1, PSMC1]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[CREBBP, HSPH1, DNAJC7, BAG3, BAG1, EP300, FKBP4, IER5]
GO:0060020;Bergmann glial cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;23.8388145050385;7.697632086000634;7.978636679434658E-4;0.7167775754447168;[ABL1]
GO:1900275;negative regulation of phospholipase C activity;8.0;1.0;0.875;9.628524252492122;83.36451349999537;9.083926447120524;0.002790135243653613;0.839552420951524;[ABL1]
GO:0006700;C21-steroid hormone biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.541512875502493;273.07210051700156;7.004484905440688;0.00913947745536895;0.7091290490632969;[STARD3, FDXR]
GO:1903427;negative regulation of reactive oxygen species biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;200.2914960164085;6.686031174322154;0.00670357612102564;0.692843310444282;[CAV1, CTNS, PARK7]
GO:1903428;positive regulation of reactive oxygen species biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;199.60627806379105;5.948432231191374;0.0066806424928076555;0.6551224661907153;[P2RX4, ITGB2, PTX3, PARK7, PKD2]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[SF3B5, SF3B2, WBP4, EIF4A3, DDX23, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, RNF113A, PABPN1, RAVER1, PCF11, U2AF2, POLR2B, DHX16, SNRPB2, POLR2G, SMNDC1, DCPS, RBM5, AQR, PRPF38A, RBM15, GPKOW, BUD31, CPSF3, NONO, CPSF2, TFIP11, CWC15, LSM5, SRRM1, PRPF4, PSPC1, PRPF3, SNRPG, CD2BP2, SLU7]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[FGA, SERPINA3, WDR1, BRPF3, ITGB3, FGG, RAB27B, THBS1, CLEC3B, LAMP2, CD9, PHACTR2, FAM3C, CALM1, ALDOA, A2M]
GO:0071394;cellular response to testosterone stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;389.00028322827603;7.697632086000634;0.01301948940212445;0.7167775754447168;[ROCK2, ELK1, AACS]
GO:0048147;negative regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.87354995152188;6.409777797693995;0.0021377902344145586;0.6509166472493662;[SFRP1, MYC, TP53INP1, TRIM32, B4GALT7, EMD]
GO:0048025;negative regulation of mRNA splicing, via spliceosome;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;1181.5966005326304;6.781341354126479;0.03954697485192635;0.7620391240755716;[PTBP1, U2AF2, C1QBP]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[SEPT11, PDCD6IP, KIF23, RHOC, CIT, SPAST, SON, ESPL1, KIF4A, CFL1, JTB, CHMP4B, KIF20A, ECT2]
GO:0071397;cellular response to cholesterol;7.0;1.0;0.8509193652572005;9.628524252492122;437.70633080531786;7.212124270218933;0.014649636981931075;0.7197477358342742;[LRP8, AACS]
GO:0071279;cellular response to cobalt ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;8.390779266560578;0.002604253811492351;0.7522251544931926;[SERPINF1, ATP7A]
GO:0042723;thiamine-containing compound metabolic process;5.0;0.811012628672052;0.6957473261969462;9.517298617381897;171.22303227662272;7.8311634786251565;0.005730680799573931;0.6907270763441554;[SLC25A19]
GO:1900042;positive regulation of interleukin-2 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;8.67846133901236;0.02521906460756386;0.8590579283277371;[ABL1]
GO:0002590;negative regulation of antigen processing and presentation of peptide antigen via MHC class I;7.0;0.8653626801206646;0.7836007053175329;9.461470167828956;74.11733779931194;9.083926447120524;0.0024806405948695647;0.8154717862087246;[TAPBPL]
GO:1904528;positive regulation of microtubule binding;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;48.10964489978194;7.9853141584524145;0.0016101865189262975;0.7314896500084853;[PPP2CA, ABL1, MAPRE3, MAPRE1]
GO:0006702;androgen biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;272.3789533364416;7.379178354882098;0.00911627844302757;0.728290889492758;[SCARB1]
GO:0006707;cholesterol catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;394.5590965539014;7.292166977892469;0.013205537881525935;0.7238411236270654;[HSD3B7, SCARB1, SNX17, SCARF1]
GO:0072356;chromosome passenger complex localization to kinetochore;9.0;1.0;0.896240625180289;9.628524252492122;77.97647591180989;9.777073627680469;0.0026098024744960558;0.896240625180289;[RCC2]
GO:0070059;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.12593595584649;6.343086423195323;0.002815619368015229;0.6753050999230941;[ERN1, XBP1, TNFRSF10B, TRIB3, BBC3]
GO:0016569;covalent chromatin modification;5.0;0.5374962537808747;0.5589891387513577;7.383097573338024;32.63830298611046;3.836902374960038;0.001092374628379458;0.4864603777505843;[SETD5, USP36, CRTC2, HDAC3, SETD3, PAXIP1, HDAC1, SUV39H1, ARID4A, YEATS4, CHD1, RLF, RPS6KA4, CCNB1, RPS6KA5, RBBP5, SIN3A, ZNF407, EP300, USP51, SUDS3, RBBP7, MTA2, RNF20, ZNF462, HELLS, DR1, CREBBP, UBE2B, DTX3L, SETDB1, EYA2, BRPF3, PRMT3, VRK1, SIRT2, POLE4, DDB1, PER2, BRMS1, TBL1XR1, IRF4, CDK2, POLE3, ZFP64, TAF5, EZH2]
GO:0060563;neuroepithelial cell differentiation;6.0;0.7671156992804218;0.7066781622303554;8.801845679307654;25.58801435984686;6.686031174322154;8.564078129062366E-4;0.665044257777226;[ABL1]
GO:1900210;positive regulation of cardiolipin metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;291.20136029582517;9.083926447120524;0.00974624746489165;0.8607930461318132;[STOML2]
GO:0036297;interstrand cross-link repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;5.905872616772578;0.006126539929698291;0.6770266002729131;[RAD51AP1, FANCI, DCLRE1A, DCLRE1C, RAD51, UBE2T, RFWD3, FANCE]
GO:0045047;protein targeting to ER;10.0;0.8933024483968273;0.861892236059334;9.54514264355307;184.61581431307337;5.142344639450834;0.00617892516161263;0.6782207558659173;[RPS15, RPS9, SPCS2, RPL3, PMM1, RPS7, PMM2, SRP54, CHMP4B, RPL23A, RPL29, RPL19]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, AHCYL1, RPL3, NUP107, NCF1, ZDHHC6, IPO4, RAB43, RPH3A, RPS15, IPO8, IPO9, LAMP2, LONP2, ARFIP1, HOMER3, TBC1D22A, SIL1, VPS18, GSTK1, RPS9, RPS7, COG3, AP1B1, TOMM34, TBC1D2B, MYO7A, SYTL3, BCR, NUP93, CHMP4B, RPL29, SLC27A2, KPNB1, ACOT4, COPB2, COPA, VPS26B, HSP90B1, NCKIPSD, VPS11, RAB6A, VPS16, AP1M1, PMM1, RAB3IP, PMM2, NUP153, RAB27B, TIMM44, NFKBIA, POLA2, PAN3, NPLOC4, CDK5, BCL3, HYOU1, ARF3, TRAM1, YWHAB, SRP54, CLTA, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TNPO2, ARL5A, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, TBC1D8, ACOX2, AGPS, SLU7, RABGAP1, TOMM40, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, RAB40C, LMNA, AP2S1, HEATR3, STX5, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, AGK, SYVN1, RPL23A, RAB11A, ARCN1, SPCS2, SNX17, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, VPS45, SEC24C]
GO:0003376;sphingosine-1-phosphate signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;50.14720301582843;7.292166977892469;0.001678381755387122;0.6960420709600095;[SPHK2, SPHK1, SPNS1]
GO:0050872;white fat cell differentiation;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.75937296335754;7.292166977892469;7.282666309192915E-4;0.6631627702307852;[PER2, TBL1XR1, AACS]
GO:0006517;protein deglycosylation;7.0;0.7671156992804218;0.7344772148974115;9.326243380619188;247.8243933626011;6.311337724880743;0.008294459418372403;0.6736814700148209;[RNF103, MAN2B2, EDEM1, SYVN1, DERL2, MAN2B1, MAN1B1, PARK7]
GO:0045292;mRNA cis splicing, via spliceosome;12.0;1.0;0.9481203125901445;9.628524252492122;357.76734256588776;6.444869117505266;0.011974150985975996;0.7777112189764279;[RNF113A, WBP4, CWC15, DCPS]
GO:0071333;cellular response to glucose stimulus;8.0;1.0;0.875;9.628524252492122;272.3004295980195;5.69953618377475;0.009113650324169357;0.6664745454937787;[ERN1, XBP1, ENDOG, SIN3A, SERPINF1, AACS, NME1]
GO:2000157;negative regulation of ubiquitin-specific protease activity;10.0;1.0;0.9152410118609203;9.628524252492122;499.22526197256934;9.083926447120524;0.016708620244655432;0.8797934328124444;[PARK7]
GO:0070126;mitochondrial translational termination;7.0;1.0;0.8509193652572005;9.628524252492122;40.68669918132259;5.277263957350204;0.0013617472059468932;0.6207988894539612;[MRPL30, MRPL40, MRPS16, MRPS24, MRPS36, MRPS22, MRPS18B, MRPS18A, MRPL17, MRPL37, MRRF]
GO:2000277;positive regulation of oxidative phosphorylation uncoupler activity;10.0;1.0;0.9152410118609203;9.628524252492122;289.2817099287976;9.777073627680469;0.009681998494680407;0.9152410118609203;[PARK7]
GO:0070125;mitochondrial translational elongation;7.0;1.0;0.8509193652572005;9.628524252492122;106.95016378538953;5.299736813202263;0.0035795257329985885;0.6219481523473303;[MRPL30, MRPL40, MRPS16, MRPS24, MRPS36, MRPS22, MRPS18B, MRPS18A, MRPL17, MRPL37]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[ENDOG, SUV39H1, RORA, AQP3, SIRT2, AQP1, NPEPPS, SFRP1, CCNB1, TBL2, MYC, LMNA, UBQLN1, HYOU1, ATP7A, KCNK3]
GO:0050995;negative regulation of lipid catabolic process;7.0;0.7671156992804218;0.7344772148974115;9.0689084645567;114.83297947662612;6.686031174322154;0.003843356480110741;0.692843310444282;[BSCL2]
GO:2001020;regulation of response to DNA damage stimulus;6.0;0.5902001590945054;0.6182203921373972;8.01908634005802;29.43425144606613;4.530049555519983;9.851379067933503E-4;0.5547872575282844;[SMG1, PCNA, PAXIP1, CEBPG, BRCA1, RAD51AP1, BCL2L12, BCLAF1, MYC, ABL1, USP51, BID, ZNF365, IER3, POLQ, FBXO18, DTX3L, EYA2, FEM1B, WRNIP1, TFIP11, DEK, SENP2, CDK9, RINT1, RAD51, RFWD3, TIMELESS, TRIM32]
GO:2001022;positive regulation of response to DNA damage stimulus;7.0;0.7043150770688792;0.7030769037916401;8.890925309361343;86.91339641844894;5.382624473008031;0.0029089131611469855;0.6261870311244675;[BCLAF1, PCNA, PAXIP1, FBXO18, DTX3L, EYA2, MYC, CEBPG, TIMELESS, BRCA1]
GO:1901671;positive regulation of superoxide dismutase activity;9.0;1.0;0.896240625180289;9.628524252492122;578.3848868100486;8.67846133901236;0.019358021648928737;0.8400575416471059;[PARK7]
GO:0006893;Golgi to plasma membrane transport;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;32.11060110714162;5.845247994956144;0.0010747129213912287;0.6498456195510879;[BBS2, ARF3, ARFGEF2, SYS1, COMMD1, VAMP5, EXOC1]
GO:0006771;riboflavin metabolic process;5.0;0.8933024483968273;0.736892236059334;9.503361109538115;127.52420954234478;7.8311634786251565;0.004268120529044823;0.6907270763441554;[FLAD1]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[COLEC12, SCARB1, FCER1G, CD163L1, TFRC, AMBP, CAV1, ITGB2, CLTA, FNBP1L, RABEPK, LRP8, AGER, HSP90B1, GAK, CLN3, HSPH1, SYNJ1, SNX17, AP2S1, CD9, HYOU1, APOL1, SCARF1]
GO:0006656;phosphatidylcholine biosynthetic process;8.0;0.7980440201809971;0.7740220100904985;9.398000593880289;749.286726231254;6.343086423195323;0.025077952412686653;0.6993857346658935;[FABP5, STARD7, STARD10]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[TRAPPC2, TRAPPC3, PPP6C, SEC13, TRAPPC2L, TFG, TBC1D20, TRAPPC6B, TMED2, STX5, KLHL12, SEC24C]
GO:0006412;translation;7.0;0.8653626801206646;0.7836007053175329;9.510741216835738;402.5585345733233;4.39257856489138;0.01347327187300917;0.5755560373415389;[HBS1L, RPL3, MRPS16, MRPS36, RRBP1, MRPL37, RPS15, RPL36AL, HARS, RPL19, RPL39L, RPS9, NDUFA7, MRPS24, RPS7, MRPS18B, MRPS18A, SARS, RPL23A, RPL3L, COPS5, RPL7L1, RPL22L1, RPL29, MRRF, CPEB4]
GO:0006406;mRNA export from nucleus;9.0;0.8933024483968273;0.8428918493787028;9.523163736834295;121.36021434248079;5.132682728539097;0.004061817156940898;0.658726258611935;[SMG1, SEH1L, NUP107, POLDIP3, EIF4A3, CASC3, SMG5, ALKBH5, NXF3, PABPN1, U2AF2, TPR, NUP62, NUP43, RAE1, UPF2, UPF1, CPSF3, CPSF2, NUP153, THOC2, SRRM1, THOC6, NUP93, SLU7]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[TBX1, GSTK1, CSTA, PCNA, HDAC1, ITGA2, VIL1, FZR1, RXRA, LBH, NFIB, CASP3, ABL1, CCM2, TPP1, ALDOC, E2F7, E2F8]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, COPA, DCTN4, GOSR1, DCTN3, KLHL12, TEX261, RAB43, SPAST, TFG, TMED2, STX5, TMED1, TMED4, TRAPPC2, TRAPPC3, TMED9, TRAPPC2L, COG4, COG3, DDHD2, COG1, DYNLL2, SPTB, ARFGAP1, YIF1A, ARCN1, TBC1D20, TMEM115, TRAPPC6B, GOLGB1, HYOU1, SEC24C, SEC22C]
GO:0007614;short-term memory;7.0;1.0;0.8509193652572005;9.628524252492122;22.22653164046661;7.57984905034425;7.439020114266185E-4;0.738553198190834;[SERPINF1, ADNP, COMT]
GO:0046033;AMP metabolic process;10.0;0.8259837884571596;0.8282329060895002;9.507163395487854;913.4888691002259;7.292166977892469;0.03057365036217675;0.7881627702307852;[PRPS2, ADK, AK3]
GO:0030850;prostate gland development;5.0;1.0;0.7902410118609202;9.628524252492122;53.04415849917153;7.379178354882098;0.0017753402483239472;0.6676125360964777;[FKBP4]
GO:0050764;regulation of phagocytosis;7.0;0.6873818243518346;0.6946102774331178;9.05316010758856;47.10255867462412;5.4730085344763;0.0015764802492890249;0.6308092762312435;[SCARB1, FCER1G, ITGA2, SIRPG, C2, BCR, C3, ABR, PTX3, NCKAP1L, CSK, DOCK2, ATG5]
GO:0098706;ferric iron import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;329.4898826815344;7.9853141584524145;0.011027729851708358;0.8407982897480031;[ARHGAP1]
GO:0030974;thiamine pyrophosphate transmembrane transport;7.0;0.9326813400603323;0.8172600352873667;9.57973408832269;278.1274359885791;9.083926447120524;0.009308674984096104;0.8154717862087246;[SLC25A19]
GO:2001136;negative regulation of endocytic recycling;7.0;1.0;0.8509193652572005;9.628524252492122;151.91783127345857;9.777073627680469;0.0050845530955509425;0.8509193652572005;[ARHGAP1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, UBE3A, BRCA1, UBE2Z, UBE2L3, TRIM9, NPEPPS, HERC4, TRIM7, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, RNF44, FBXO18, DTX3L, ARRDC1, ZFP91, TRPC4AP, DDB1, KCTD10, MED20, ANAPC5, THOP1, HIST1H2BC, ANAPC13, HIST1H2BO, PCNA, HIST1H2BJ, CDCA3, MGRN1, RNF38, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, VCPIP1, FZR1, RNF213, RAB40C, UBD, HLTF, RFFL, RNF20, UBE2I, UBE2B, KLHL25, FEM1B, SYVN1, FBXL15, LNPEP, FBXL16, MARCH3, CNOT4, ITCH, SPSB1, RNF103, KLHDC8A, UBE2T, RFWD3, TSPAN17, KBTBD2, CDC16, FBXL3, TRIM32, ASB3, KBTBD8]
GO:0035066;positive regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1302.9179711131005;6.444869117505266;0.043607491943109866;0.7620198587159455;[RPS6KA4, RPS6KA5, PAXIP1, WBP2, BRCA1]
GO:0046039;GTP metabolic process;10.0;0.8933024483968273;0.861892236059334;9.574457031221845;1313.8843925894662;6.311337724880743;0.043974528200785255;0.7380031166185408;[IMPDH2, AK3, GPHN, NME1]
GO:0090073;positive regulation of protein homodimerization activity;6.0;1.0;0.8231203125901445;9.628524252492122;47.416497719221994;7.57984905034425;0.0015869875065849188;0.710754145523778;[GNL3L, PARK7]
GO:0006744;ubiquinone biosynthetic process;7.0;0.8259837884571596;0.7639112594857803;9.405380701177911;357.5406619598991;7.004484905440688;0.011966564190092859;0.7091290490632969;[COQ3, FDXR, COQ9, COQ10B]
GO:0006621;protein retention in ER lumen;8.0;1.0;0.875;9.628524252492122;48.69704458819814;7.57984905034425;0.0016298462578721894;0.7626338329336335;[ANKRD13C, RER1, GPAA1]
GO:0050892;intestinal absorption;4.0;0.811012628672052;0.655506314336026;9.176539128749065;23.07461412231494;6.375876246018314;7.722865688694012E-4;0.576062607729944;[VIL1, SCARB1, ACO1, TJP2]
GO:0046041;ITP metabolic process;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;890.1410689675724;9.083926447120524;0.02979222050339277;0.8797934328124444;[AK3]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, USP37, MAX, GMNN, MCM10, PPP6C, GPR132, PPAT, MYC, SKP2, CDKN2C, CDC7, CDC25A, POLE4, WEE1, POLA2, CDK6, CCNE2, CCNE1, POLE2, CDK2, POLE3, MCM5, MCM6, MNAT1, MCM2]
GO:0006739;NADP metabolic process;10.0;0.7980440201809971;0.8142630219514189;9.420884887713877;293.8575721815232;6.375876246018314;0.009835148486270468;0.7413036195908642;[RPIA, NNT, DCXR, IDH2]
GO:2000058;regulation of ubiquitin-dependent protein catabolic process;9.0;0.7140352122741334;0.7532582313173557;9.203641058526856;224.62789392231474;4.786641040901733;0.007518093457600162;0.6410296706135761;[RPS7, ZFAND2A, CAV1, GLMN, CLEC16A, RAD23A, UBE3A, PARK7, COMMD1, SIRT2, PDCL3, UBQLN1, PBK, TRIB3]
GO:0016310;phosphorylation;5.0;0.5310727365277519;0.5557773801247963;6.876988939450173;24.405590426795786;2.7321685105510984;8.168331479794688E-4;0.42996423654933263;[OXTR, DGKD, MAML1, CCNH, DGKA, CD80, IL5RA, BUB1B, STK19, IGF1R, RPS6KA4, RPS6KA5, RPS6KA2, MYC, CFL1, TRIM24, NEK1, SEPHS1, EPHB4, PDGFRB, CSNK2A1, PAQR3, ZFYVE21, VRK1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, CCNE1, TRIB3, EPHA1, CSNK1G2, CSNK1G1, AK2, ATP5J, AK3, ATP5I, ATP5O, PKMYT1, RASGRP4, ATP5L, STK3, NUAK1, CCNB1, STK35, STK38, ABL1, STK38L, MBP, RIPK1, CYC1, MARK2, EIF2AK3, DOLK, CDC7, ERLIN2, CLK4, EIF2S1, CLK3, NFKB1, SETX, CLK1, CDK9, GNPTG, UCK2, PAN3, CDK6, CDK5, PTPRA, FES, CDK2, FGFR1OP, CALM1, MNAT1, GPI, CIITA, SMG1, FASTKD1, MAST3, ADPGK, YWHAB, HK3, AKAP13, ZMYM2, PBK, CTSH, HRAS, DUSP5, MAP4K2, TPI1, KSR1, SPHK2, SPHK1, DCAKD, CAD, BPGM, OXSR1, ATP5F1, MASTL, GFRA2, SPTB, COASY, VAV1, NME1, CIT, GAK, ITPKB, PDIK1L, IMPAD1, KIT, FASTKD5, PIK3C3, ALDOC, ALDOA, MET, HBEGF, PRPS2, PDXK, STOML2, ROCK2, PNKP, GPS1, COX5B, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, ANGPT1, AGK, GTF2H4, P2RX7, SNRK, WEE1, TNIP2, CAMK4, TAOK2, CCM2, KRAS, CAMK1, TEK]
GO:0051987;positive regulation of attachment of spindle microtubules to kinetochore;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;141.20478198009135;8.16763571524637;0.004725996976820352;0.7686126355688037;[BECN1, CCNB1, RCC2, SIRT2]
GO:0045070;positive regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.31211810933421;6.221725566191056;0.0028553198171978322;0.6931793347948383;[DDB1, CNOT7, TBC1D20, CCL5, RAD23A, PPID]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[CNOT4, ITCH, RNF213, UBE2B, DTX3L, UBE2T, UBE3A, BRCA1]
GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;1177.790893893302;8.16763571524637;0.039419601275621635;0.8802482350792397;[PLAUR, PARK7]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[CYFIP2, NCKAP1, TFRC, WIPF2, GFI1, CD80, GPATCH3, PARK7, RPS6KA5, NPPA, EP300, IL12A, IFNAR2, LAG3, IL4R, HLA-A, HLA-F, UNC13D, BCR, KARS, CD8B, IL23A, PSPC1, ELMO1, CARD11, ANKRD17, PAXIP1, CFH, SUPT6H, AGER, C2, HSP90B1, C3, NCKIPSD, ABR, CLEC7A, ABL1, SLAMF7, NLRP3, NCKAP1L, RIPK1, A2M, HLA-DQA1, ATG5, EIF2B4, PRNP, CREBBP, XBP1, XRCC6, AMBP, CADM1, BTN2A1, XRCC5, NONO, CAV1, PILRB, PILRA, NFKB1, NFKBIA, IL6, COL1A2, NPLOC4, CNOT7, ARPC2, FES, TREML4, CALM1, HLA-DRB3, CUEDC2, SIGLEC9, C12orf4, ITGB2, ARPC1A, PTPN22, IL27, WASL, AP1G1, SIN3A, C1QBP, CTSH, CTLA4, HRAS, CCR2, HLA-DPA1, HAVCR2, FGA, ACTR2, FCER1G, PVRIG, FGG, BTN3A2, TMEM173, VAV1, DUSP22, VAMP8, IRF4, KIT, PIK3C3, LCP2, COLEC12, STOML2, NLRC4, LILRA2, TANK, RELA, UNG, HLA-DMB, CCL5, UBQLN1, LAIR2, CSK, CCL19, EXOSC3, IL12RB1, NPDC1, ANGPT1, P2RX7, ITCH, CD4, POLR3B, POLR3C, TNIP2, HLA-DPB1, MNDA, KRAS, C1QC]
GO:0006750;glutathione biosynthetic process;8.0;1.0;0.875;9.628524252492122;528.5812657394678;7.069023426578259;0.017691139272045377;0.7365101867784198;[CHAC2, CNDP2]
GO:1901215;negative regulation of neuron death;6.0;0.7586651285174919;0.7024528768488905;9.05316010758856;58.54459561550999;4.545965010825883;0.001959434928535777;0.5556011746527726;[BTG2, ANGPT1, WFS1, PARP2, NONO, SERPINF1, KIF14, PARK7, CORO1A, CLN3, CDK5, PSMC1, CHMP4B, KRAS, HYOU1, ADNP, SNCB, HRAS, CPEB4]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[TFAP2A, PRNP, CDK5, CASP3, ITGB2, DDIT4, TP53BP2, ABL1, CASP2, ELK1, EIF2S1]
GO:0006631;fatty acid metabolic process;7.0;0.5408746917014966;0.6213567111079488;7.849668188099975;91.0232021896581;4.037280715501235;0.0030464646617242943;0.5573860888006872;[ECHS1, ABCD3, HSD17B4, ETFA, ETFB, BRCA1, LIAS, ALKBH7, HSD17B8, ADIPOR2, ACACA, AACS, C3, SGPL1, CPT2, FADS1, HIBCH, XBP1, ACOT7, ELOVL5, ACSL6, ELOVL6, PRKAB1, PER2, ALDH3A2, ACLY, ALDH5A1, ACOX2, GPAM, NDUFS6, DEGS1, DAGLB, SLC27A2, ACOT4, MGLL]
GO:1902306;negative regulation of sodium ion transmembrane transport;9.0;0.7866048967936545;0.7895430735771163;9.31486669363708;301.9792406638751;7.212124270218933;0.010106973421347693;0.7650689957573628;[COMMD1]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[OXTR, STOML2, ITPR2, ATP2A2, PKD2, CLN3, GNAT2, TBXA2R, CCL5, ABL1, PDE6B, CCL19, NTSR1, CCR10, GTF2I, CCR2, ATP13A1, WFS1, CAV1, SWAP70, GPR55, P2RX7, CD4, P2RX4, CALM3, CALM1, CALM2, KCNK3]
GO:0006747;FAD biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;1696.5949498710493;9.777073627680469;0.056783506135859745;0.9152410118609203;[FLAD1]
GO:0006626;protein targeting to mitochondrion;10.0;1.0;0.9152410118609203;9.628524252492122;196.80778803422263;6.250713103064308;0.006586979549995513;0.734902770639515;[TIMM8B, TOMM40, TOMM34, TIMM44, BID]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, SFRP1, HDAC1, CAV1, DVL3, KLHL12, EMD, DACT1, STK3]
GO:0006627;protein processing involved in protein targeting to mitochondrion;8.0;1.0;0.875;9.628524252492122;185.93579430809868;7.9853141584524145;0.006223103704141256;0.7833693374183408;[PMPCB]
GO:0006506;GPI anchor biosynthetic process;9.0;0.7980440201809971;0.7952626352707877;9.474373572664863;1288.6226301771758;6.558197802812269;0.04312903974695605;0.7316271658034954;[DPM3, PIGU]
GO:0071340;skeletal muscle acetylcholine-gated channel clustering;7.0;1.0;0.8509193652572005;9.628524252492122;44.498670089768545;7.697632086000634;0.001489330441701492;0.7445766281117727;[RER1]
GO:0046051;UTP metabolic process;10.0;0.8933024483968273;0.861892236059334;9.572954401337311;1267.9134952345498;7.379178354882098;0.042435923637437784;0.7926125360964777;[CAD, AK3, NME1]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[UPF1, CXCL6, XBP1, ABCC2, CCL20, GFI1, CD80, PDCD1LG2, NFKB1, RELA, BCR, IL6, PABPN1, NLRP7, TBXA2R, TNIP2, ABL1, NLRP3, IL12A, HAVCR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, DEFB1, IL27, LYST, PPP6C, C1QBP, HAVCR2, FGA, MAP4K2, FCER1G, DTX3L, WRNIP1, RNASE3, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, CEBPG, NLRC4, ZC3HAV1, LILRA2, CORO1A, AGER, RELA, C2, C3, CLEC7A, PRDX1, NLRP2, ABL1, SLAMF7, NLRP3, CSK, APOL1, XRCC6, APOBEC3F, APOBEC3H, XRCC5, NONO, NFKB1, ITCH, POLR3B, POLR3C, FES, TREML4, POLR3E, PTX3, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[FLCN, ERRFI1, NLRP12, ABL1, CSK]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[CYFIP2, CCNF, PREP, BUB1B, UBE3A, PARK7, UBE2Z, UBE2L3, CNDP2, YY1, PSMD8, NPEPPS, PSMD7, PSMD4, PSMD2, CDC26, MYC, LONP2, PMPCB, SKP2, C18orf25, RNF44, FBXO18, ARRDC1, TRPC4AP, KCTD5, CDC25A, SFRP1, KCTD10, TBL1XR1, PSME2, CHMP4B, ANAPC5, UBR4, COPS7B, COPS7A, ANAPC11, C2, HSP90B1, C3, VCPIP1, CCNB1, RHOT1, RNF213, UBD, NLRP3, USP51, RIPK1, AMZ2, XBP1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, WFS1, EDEM1, RHBDD1, LNPEP, ERLIN2, BTBD6, PGA3, PGA5, NFKB1, NFKBIA, NSFL1C, COPS5, RNF103, NPLOC4, CDC16, FBXL3, TPP1, USP36, USP37, WDR48, PPP1R11, USP32, USP34, KIF14, OTUD7B, BRCA1, ECE2, USP39, SENP6, POLB, TRIM9, CTSO, SCRN1, CASP3, CASP2, CTSH, CTSE, USP46, FGA, SEC13, PDCD6IP, DTX3L, RHBDF2, FGG, RAD23A, SENP2, JOSD1, SIRT2, DDB1, PSMA1, ESPL1, PIK3C3, MAN1B1, USP41, THOP1, MPND, BECN1, STOML2, DERL3, GPS1, RNF38, USP12, DERL2, NEDD8, LRP8, TANK, PARL, PSMB10, PSMA7, RELA, ARNTL, TFPT, CLN3, FZR1, PSMB5, TP53INP2, PERP, PSMB1, ADAM23, UBQLN1, RFFL, SEC11A, SEC11C, RNF20, LRRC29, SYVN1, FBXL15, FBXL16, CAPN13, P2RX7, KBTBD4, ITCH, SPSB1, SPCS2, XPNPEP1, FAP, TNIP2, PSMC1, TRIM32, C1QC, MAD2L1, METAP2]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PDGFRB, FGA, ANGPT1, CCL20, RYK, FGG, GPR55, CIB1, PTPN22, AGER, IGF1R, RAP1B, CD4, KARS, CCL5, KIT, ABL1, CCL19, TEK, EPHA1, HRAS, MET, EPHB4, HAVCR2]
GO:0030950;establishment or maintenance of actin cytoskeleton polarity;6.0;1.0;0.8231203125901445;9.628524252492122;64.1120899346335;7.212124270218933;0.002145773952977257;0.6919486831672181;[RHOC, AQP1]
GO:0106046;guanine deglycation, glyoxal removal;9.0;1.0;0.896240625180289;9.628524252492122;173.84337223153733;9.777073627680469;0.005818381219712067;0.896240625180289;[PARK7]
GO:0106045;guanine deglycation, methylglyoxal removal;9.0;1.0;0.896240625180289;9.628524252492122;262.0657266346724;9.777073627680469;0.008771104026620792;0.896240625180289;[PARK7]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[PDGFRB, BECN1, NCF1, ANGPT1, CCL5, KIT, UBE3A, TEK]
GO:1902036;regulation of hematopoietic stem cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;97.61516402498306;6.558197802812269;0.003267091691972132;0.6863059058804069;[ITCH, ABL1]
GO:1903122;negative regulation of TRAIL-activated apoptotic signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;492.3916484136839;9.777073627680469;0.016479905348692456;0.9324289523296623;[PARK7]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[AHCYL1, RPL3, NUP107, TFRC, ZDHHC6, RPS15, LONP2, ARFIP1, HOMER3, TBC1D22A, SIL1, VPS18, GSTK1, ARRDC1, COG4, COG3, AP1B1, COG1, MYO7A, SYTL3, SCAMP3, BCR, RUFY1, NUP93, UNC50, KIF20A, RPL29, ACOT4, VPS26B, ABCB9, VPS8, VPS11, ATP6V0A2, VPS16, BBS2, XBP1, PMM1, RAB3IP, PMM2, RAB27B, POLA2, NPLOC4, HYOU1, ARF3, TRAM1, AHCTF1, SRP54, ARHGAP1, CLTA, LYST, TRAM2, XPO5, KIF13B, TMED2, TMED1, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, BTN3A2, COMMD1, VAMP8, AFTPH, LSG1, GAL, AGPS, EXOC3, SLU7, VAMP5, PAFAH1B1, EXOC1, RABGAP1, TOMM40, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, GGA3, SNX25, LMNA, AP2S1, HEATR3, STX5, CCL19, BID, RAE1, RPL19, PEX16, PEX19, AGK, SYVN1, RAB11A, YIF1A, ARCN1, CENPF, SPCS2, SNX19, GPAM, SNX17, SNX14, TAOK2, RAB3GAP2, APBA3, RAB3B, SYS1, DGKD, NCF1, PARK7, IPO4, RAB43, RPH3A, EIF4ENIF1, IPO8, IPO9, LAMP2, RPS9, RPS7, VPS33A, VPS33B, TOMM34, TBC1D2B, RINT1, CHMP4B, SLC27A2, KPNB1, PPID, CARD11, COPB2, COPA, SUCNR1, HSP90B1, NCKIPSD, NLRP3, ECT2, RAB6A, ATP6V1F, AP1M1, TOR1A, VTA1, NUP153, TIMM44, NFKBIA, PAN3, CDK5, TMEM115, BCL3, SFT2D3, YWHAB, GPR89B, AP1G2, AP1G1, NUP62, EVI5L, TNPO1, TNPO2, SNAP29, ARL5A, PDCD6IP, DTX3L, RHBDF2, FGG, TBC1D8, SENP2, ARFGAP1, ACOX2, LCP2, CHMP6, SEC22C, GOSR1, RRBP1, NLRC4, RAB21, AP3M1, RAB20, RAB40C, VPS52, VPS54, RAB28, TIMM8B, ARFGEF2, RPL23A, MCM3AP, VPS41, RAB13, RAB18, RUNDC1, VPS45, SEC24C]
GO:0042770;signal transduction in response to DNA damage;6.0;0.7586651285174919;0.7024528768488905;9.34084218004034;57.72882169830185;5.142344639450834;0.0019321317096756808;0.5861000565951415;[BTG2, CDKN1A, PCNA, PAXIP1, BRCA1, CCNB1, FZR1, ABL1, CASP2, EP300, BID, GTSE1, E2F7, E2F8, CNOT10, CNOT4, CNOT6, TFDP1, CNOT7, TFDP2, CNOT1, BCL3, CNOT3, CDK2, CNOT8]
GO:0006446;regulation of translational initiation;8.0;0.622025257344104;0.686012628672052;8.744321835169467;215.8173094633638;5.433268205826786;0.007223211124770292;0.6528575887187926;[EIF5B, RXRA, KLHL25, YTHDF3, CCL5, TPR, EIF2AK3, POLR2G, EIF2S1, MIF4GD, EIF4G2]
GO:0042776;mitochondrial ATP synthesis coupled proton transport;13.0;1.0;0.9625549647676366;9.628524252492122;10144.915177257948;6.943860283624253;0.3395411811519228;0.8176643025947071;[STOML2, ATP5J, ATP5I, CYC1, COX5B, ATP5O, ATP5F1, ATP5L]
GO:1990001;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;13.0;1.0;0.9625549647676366;9.628524252492122;2010.8653136723324;7.292166977892469;0.06730185238732382;0.8354767231375014;[BCL2L12, NLRC4, UBE2Z]
GO:0097484;dendrite extension;5.0;1.0;0.7902410118609202;9.628524252492122;51.99108915072818;7.474488534686424;0.0017400949649324319;0.6724867031240476;[CYFIP2, SLC9A6]
GO:0006437;tyrosyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;9.083926447120524;0.006875708083302461;0.8969813732811862;[YARS]
GO:0051000;positive regulation of nitric-oxide synthase activity;7.0;1.0;0.8509193652572005;9.628524252492122;123.23454311126406;6.832634648514029;0.0041245492540456985;0.7003406189322132;[SCARB1, KRAS]
GO:0019640;glucuronate catabolic process to xylulose 5-phosphate;10.0;1.0;0.9152410118609203;9.628524252492122;580.1685481574996;8.16763571524637;0.019417719189036925;0.8329342821725234;[DCXR]
GO:0010811;positive regulation of cell-substrate adhesion;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;35.30989762708448;5.049685808968129;0.0011817904967337807;0.5484821789659555;[FGA, PLEKHA2, FGG, ARL2, CIB1, UNC13D, SFRP1, CDK6, ARPC2, C1QBP, ABL1, TEK, EPHA1, LIMS1, S100A10]
GO:0016255;attachment of GPI anchor to protein;7.0;1.0;0.8509193652572005;9.628524252492122;151.15475272427284;7.9853141584524145;0.005059013543235805;0.7592887026755414;[PIGS, PIGU, PIGT, GPAA1]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[DCTN6, DCTN5, DCTN4, DCTN3, CLTA, KLC1, KIF15, HLA-DMA, HLA-DMB, ACTR1B, KIF3B, AP1G1, AP2S1, CTSE, HLA-DQA1, HLA-DPA1, AP1M1, LAG3, SEC13, FCER1G, AP1B1, KIF23, DYNLL2, CENPE, KIF4A, HLA-DPB1, KIF2C, HLA-DRB3, SEC24C]
GO:0016259;selenocysteine metabolic process;9.0;0.8933024483968273;0.8428918493787028;9.503361109538115;86.36097084856158;8.390779266560578;0.002890423974473591;0.8253454670833372;[SARS, SEPHS1]
GO:0030302;deoxynucleotide transport;7.0;1.0;0.8509193652572005;9.628524252492122;68.1491615590043;9.777073627680469;0.0022808911071163685;0.8509193652572005;[SLC25A19]
GO:1902041;regulation of extrinsic apoptotic signaling pathway via death domain receptors;9.0;0.8259837884571596;0.8092325194088689;9.485423408851448;64.8607677845634;5.734022359845919;0.0021708315268480906;0.6894787953221185;[FGA, FEM1B, FGG, TNFRSF10B, TNFRSF10A, BRCA1, PARK7, THBS1, STK3, SFRP1, MADD, RIPK1, RFFL]
GO:1905555;positive regulation blood vessel branching;8.0;1.0;0.875;9.628524252492122;279.2097811632757;9.083926447120524;0.009344900103045782;0.839552420951524;[ABL1]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP2, NCKAP1, TBCCD1, ITGB3, LST1, KIF14, THOC2, P2RX7, PARVG, VSIG1, TBC1D20, COL4A4, ABL1, NCKAP1L, TEK, ECT2, EPHA1, SOX6, MET]
GO:2000096;positive regulation of Wnt signaling pathway, planar cell polarity pathway;9.0;1.0;0.896240625180289;9.628524252492122;350.0359368300977;7.697632086000634;0.011715387793812527;0.7898978880348613;[ABL1]
GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;11.0;1.0;0.9324289523296623;9.628524252492122;2131.9864477698584;7.212124270218933;0.07135566774362433;0.8012573229067359;[BCL2L12]
GO:0014074;response to purine-containing compound;5.0;0.7140352122741334;0.6472586179979869;8.801845679307654;47.95118194361459;4.807260328104469;0.0016048829063907782;0.5360845286006501;[IGFBP5, CAD, ITPR2, PKD2, RELA, AACS, HSP90B1, NME1, AQP1, RAP1B, P2RX7, P2RX4, XRN1, SDC1, TEK]
GO:0006695;cholesterol biosynthetic process;7.0;0.8653626801206646;0.7836007053175329;9.50592193039979;430.3580998185219;6.039404009397101;0.014403698303781551;0.6597747671587765;[ACLY, SQLE, EBP, NSDHL]
GO:0045930;negative regulation of mitotic cell cycle;6.0;0.5833093054345528;0.6147749653074209;7.836764783264067;61.236897459641845;4.271742091748107;0.0020495438483445192;0.5415774018184651;[TOP2B, BTG2, CDKN1A, ZWILCH, BUB1B, BRCA1, PKD2, GPR132, ZNF207, CASP2, EP300, KNTC1, TOPBP1, GTSE1, HRAS, DACT1, TIPIN, TFDP1, RBL1, TFDP2, CTDSP2, MCPH1, PCNA, XPC, CCNB1, RAD21, TPR, ABL1, E2F7, E2F8, FANCI, INTS3, DONSON, MAD2L1BP, CNOT10, ZWINT, CNOT4, CNOT6, CENPF, WEE1, CNOT7, FAP, CNOT1, RFWD3, CNOT3, TAOK2, CDK2, CNOT8, EZH2, MAD2L1]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[POLB, CDKN1A, BCL3, DDIT4, ABL1, CASP2, EP300, BRCA1]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[PDGFRB, BECN1, PCNA, PARK7, RELA, AQP1, SETX, IL6, CASP3, PPIF, ABL1, SDC1, ECT2, EZH2]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[CYFIP2, NCF1, MAML1, GFI1, CD80, CIB1, UBE3A, PARK7, IGF1R, TFG, ARL6IP5, EP300, IL12A, SKP2, EPHB4, PDGFRB, CSNK2A1, FBXO18, IGFBP5, RPS7, SLC35C2, MAPK8IP3, ERN1, NUP93, DEPDC1B, SFRP1, TWSG1, KARS, IL23A, TBL1XR1, MADD, PPIF, EPHA1, CARD11, ANKRD17, SEH1L, CLEC16A, AGER, RASGRP4, STK3, MTDH, C3, RAP1B, UBD, TP53BP2, ABL1, DVL3, RIPK1, ECT2, NTSR1, CREBBP, XBP1, UBE2I, CAV1, STARD10, TNFRSF10B, TNFRSF10A, NFKB1, IL6, CDK5, ARL2BP, TREML4, CALM3, SERINC3, CALM1, CALM2, EZH2, CDKN1C, HRK, BCAR3, YWHAB, ITGB3, USP34, ARHGAP1, PTPN22, PKD2, BBC3, FLCN, AKAP13, PTBP1, C1QBP, NUP62, CASP2, CTSH, HRAS, DACT1, HAVCR2, TMED4, FGA, DUSP5, MAP4K2, SEC13, KSR1, BUD31, SPHK1, ATPIF1, FGG, PLAUR, ZFP91, ARNT, ZDHHC13, RHOC, YWHAZ, VAV1, ITPKB, DUSP22, TFDP1, ALS2, TFDP2, KIT, MET, ARHGEF5, PAFAH1B1, HBEGF, BECN1, HDAC3, WBP2, SLC20A1, TUBD1, THBS1, RELA, ARNTL, BCLAF1, CCL5, TP53INP1, CSK, ZNF622, CCL19, BID, TBX1, MAP3K3, PDE6H, ANGPT1, CCL20, RYK, GPR55, G0S2, FBXL15, P2RX7, CD4, NLRP12, P2RX4, TNIP2, TSPAN17, TAOK2, KRAS, TEK, TRIM32, LIMS1]
GO:0045931;positive regulation of mitotic cell cycle;6.0;0.6073376606709605;0.6267891429256247;8.04155919591008;60.92102604112766;4.779861353916354;0.0020389719162326697;0.5675626445157116;[ANKRD17, PDGFRB, BECN1, SPHK1, RCC2, NSMCE2, MEPCE, CDC7, NDC80, RAB11A, CDC25A, ANAPC11, NSFL1C, NIPBL, CCNB1, RAD51C, ESPL1, SIN3A, TPR, NUP62, ABL1, ANAPC5, PAFAH1B1, MAD2L1]
GO:0008627;intrinsic apoptotic signaling pathway in response to osmotic stress;7.0;0.9326813400603323;0.8172600352873667;9.574457031221845;131.18513504025643;9.083926447120524;0.004390648410840883;0.8154717862087246;[CASP3]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[MTPN, NCKAP1, WDR1, ROCK2, WIPF2, ARPC1A, WASL, IQGAP2, CORO1A, AKAP13, ARHGDIB, CFL1, PPFIA1, ABL1, NCKAP1L, ARFIP1, HRAS, CLASP1, S100A10, VASP, PDGFRB, ACTR2, SWAP70, RHOC, SSH3, SPTB, CIT, VIL1, CCDC88A, SFRP1, ARPC2, CDK5, FES, TAOK2, TEK, EPHA1, MET, ARHGEF5]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[SFRP1, ABL1, EPHA1, ARHGEF5, S100A10]
GO:0016241;regulation of macroautophagy;7.0;0.6729672293956388;0.6874029799550199;8.606873004960141;45.30384692040349;4.7081694254602375;0.0015162789856107417;0.5916953686275062;[BECN1, USP36, CALCOCO2, CLEC16A, VPS26B, ERN1, CDK5, CASP3, ATP6V0A2, CHMP4B, RAB3GAP2, RAB3GAP1, EXOC1]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[CYFIP2, FGA, STOML2, RHBDF2, FGG, ECE2, P2RX7, CLN3, SPCS2, PERP, CASP3, CASP2, CTSH, LONP2, PMPCB, PIK3C3, CTSE, SEC11A, SEC11C, METAP2]
GO:0016486;peptide hormone processing;7.0;0.7980440201809971;0.7499413753476991;9.328419660041783;182.775265034119;6.280566066213989;0.006117323633632836;0.6721078059595746;[ECE2]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[DPAGT1, CRTC2, DGKD, YWHAB, PKD2L1, IKZF1, PKD2, CLYBL, GLS, IGF1R, PPAT, NUP62, HRAS, PDCD6IP, KCND1, FCER1G, TRAPPC2L, GPX3, DCXR, ATPIF1, PRKAB1, KCTD5, GCHFR, ALDH5A1, KCTD10, KCTD14, CHMP4B, ALDOA, COLEC12, STOML2, AHNAK, ITLN1, KCNA3, NLRC4, HSD17B8, ACACA, SPAST, RXRA, RNF213, CCL5, NLRP3, RIPK1, ECT2, BID, S100A10, VASP, POLQ, PRNP, RRM1, SEPT11, XRCC6, CPSF6, TOR1A, CAV1, EIF2AK3, P2RX7, MARCKS, COL1A2, RAD51, P2RX4, IMPDH2, TEK]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[MARCKS, SWAP70, NEDD9, LCP1, RHOC, HSP90B1]
GO:1903384;negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;5661.606453506528;9.083926447120524;0.1894888728838582;0.9126727335416687;[PARK7]
GO:0043405;regulation of MAP kinase activity;11.0;0.6634067003016617;0.7641323024804931;9.028903129943;322.70119747860093;3.951073520300019;0.0108005186673862;0.6344870359015141;[GPS1, PTPN22, THBS1, AGER, DUSP14, IGF1R, PPP2CA, AKAP13, NUP62, STK38, DVL3, RIPK1, CSK, CCL19, HRAS, PDGFRB, MAP3K3, DUSP5, MAP4K2, KSR1, PDE6H, CAV1, PAQR3, MAPK8IP3, ERN1, DUSP22, P2RX7, SFRP1, KARS, TAOK2, KIT, MADD, KRAS, TRIB3, ARHGEF5, EZH2]
GO:1902177;positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;10.0;0.8933024483968273;0.861892236059334;9.572954401337311;997.8216934127827;7.9853141584524145;0.03339619409730364;0.8236103492792612;[PARK7]
GO:0006784;heme a biosynthetic process;8.0;1.0;0.875;9.628524252492122;765.506195463233;9.083926447120524;0.025620803451306372;0.839552420951524;[COX15]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[NDUFB7, NDUFB10, NCF1, COX15, COX4I1, NDUFA10, ETFA, ETFB, COX5B, COX6A1, AKR7A2, IDH3B, PMPCB, CYC1, BID, NDUFA7, TXNRD1, COQ9, UGDH, COX7A2L, ALDH5A1, NDUFS8, NDUFS7, UQCRQ, NDUFS6, DEGS1]
GO:0006661;phosphatidylinositol biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.237657943805111;661.808482261977;4.917261223318797;0.022150134312343243;0.6264689676365554;[RUFY1, ARF3, VAC14, DPM3, PIGU, SYNJ1, PLEKHA2, PIK3C3, SBF1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, MAML1, CCNH, GFI1, ARID4A, RORA, YEATS4, UBE3A, IKZF1, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, PAXIP1, MAX, RLF, SUPT6H, BCL2L12, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, PKD2, FLCN, NIPBL, SIN3A, HRAS, ZNF485, KLF13, RBM15, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIA, NFIB, TNIP2, TTC5, NFIC, PSMC1, TAF7, CAMK1, MIXL1]
GO:0006303;double-strand break repair via nonhomologous end joining;9.0;0.8933024483968273;0.8428918493787028;9.548481544818586;368.8093148901945;5.8067817141283475;0.012343715862540626;0.693199712083778;[POLQ, DCLRE1A, XRCC6, DCLRE1C, PAXIP1, XRCC5, BRCA1]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[TFAP2A, PRNP, CDK5, CASP3, CASP2]
GO:0045943;positive regulation of transcription by RNA polymerase I;11.0;0.8653626801206646;0.8651102923899945;9.54628615425515;1461.5699037633856;6.686031174322154;0.04891742935144542;0.7743528975167437;[MARS, HEATR1, EIF2AK3, WDR43]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[CYFIP2, BTG2, EIF4E3, EIF4A3, CASC3, RBM3, EIF4ENIF1, C1QBP, UPF1, EIF5B, RPS9, IGFBP5, ITGA2, MIF4GD, ILF3, XRN1, ETF1, EIF4E2, MTPN, POLDIP3, NOLC1, THBS1, FXR1, ATXN2, RXRA, CCL5, TPR, MKNK2, POLR2G, EIF2B4, KLHL25, YTHDF3, EIF2AK3, CNOT10, EIF2S1, PER2, CNOT6, IL6, CNOT7, CNOT1, CAPRIN1, BCL3, CNOT3, ACO1, CNOT8, KBTBD8, EIF4G2, TNRC6A, CPEB4]
GO:0051148;negative regulation of muscle cell differentiation;6.0;0.7090535922965819;0.6776471087384355;8.848365694942547;114.9115590436722;5.905872616772578;0.0038459864675027544;0.6251469128630576;[ANKRD17, PTBP1, XBP1, SOX6, EZH2, MED28]
GO:0051024;positive regulation of immunoglobulin secretion;9.0;1.0;0.896240625180289;9.628524252492122;579.4559284816147;7.379178354882098;0.019393868449801132;0.7736121494158466;[GPI, IL6, XBP1]
GO:0010918;positive regulation of mitochondrial membrane potential;5.0;1.0;0.7902410118609202;9.628524252492122;24.658349685322438;7.57984905034425;8.252927728937918E-4;0.6778748447945537;[STOML2, NNT, CTNS, BID]
GO:0051388;positive regulation of neurotrophin TRK receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;213.0397923327438;8.16763571524637;0.0071302501260115695;0.7686126355688037;[CYFIP2]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[CASP3, CTLA4, MNDA]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[ERRFI1, CDKN1A, ABCC2, PCNA, ABCA3, SERPINF1, CAD, UBE2L3, AQP1, IL6, CASP3, DDIT4, SDC1, KRAS]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[CCNE1, UBE3A, BRCA1, ARID1A, FKBP4, PIAS2]
GO:0051149;positive regulation of muscle cell differentiation;6.0;0.7090535922965819;0.6776471087384355;8.848365694942547;114.55096530066652;5.346256828837156;0.0038339177194376536;0.5965281354432446;[TBX1, IL4R, SETD3, MAML1, PARP2, KIT, ABL1, FLT3LG, CAMK1, TRIM32]
GO:0045717;negative regulation of fatty acid biosynthetic process;8.0;0.8436909121759173;0.7968454560879586;9.480104247373848;670.1384648150137;7.138016298065211;0.022428931331895798;0.7400384854347593;[TRIB3, ERLIN2, BRCA1]
GO:1902188;positive regulation of viral release from host cell;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;120.05257821018927;7.069023426578259;0.004018051752389216;0.7365101867784198;[DDB1, CHMP4B]
GO:0006310;DNA recombination;7.0;0.612588685250814;0.6572137078826075;8.529911963824013;149.0421272461911;4.488806596985934;0.0049883058697239;0.5804771433779154;[FEN1, WDR48, DCLRE1C, PAXIP1, BRCA1, UNG, YY1, POLB, RAD51AP1, TFPT, NIPBL, WRN, EXO1, RAD21, RAD54L, EXOSC3, POLQ, XRCC6, ENDOG, FBXO18, NCOA6, XRCC5, NONO, SWAP70, GINS4, NSMCE2, APEX2, WRNIP1, CDC7, SETX, RAD51C, RAD51, MSH3, RFWD3]
GO:0006432;phenylalanyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;8.16763571524637;0.006875708083302461;0.8501222226412654;[LRRC47]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[ABL1, CALM3, CALM1, PKD2, CALM2, NTSR1]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CASP3, NFKB1, RELA]
GO:0043534;blood vessel endothelial cell migration;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;26.070480469920426;6.599019797332524;8.725555194190899E-4;0.712474179321389;[SCARB1, EPHB4]
GO:0006434;seryl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;8.67846133901236;0.006875708083302461;0.8762458687964789;[SARS]
GO:0030514;negative regulation of BMP signaling pathway;12.0;0.8259837884571596;0.8611122068187244;9.4949928598676;599.3292772798114;5.905872616772578;0.02005901154922404;0.7501469128630576;[SFRP1, TWSG1, ABL1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TBX1, FXR1, CENPF, XBP1, SOX6, VAMP5, EMD, HBEGF]
GO:0030516;regulation of axon extension;10.0;0.7866048967936545;0.8085434602577476;9.474373572664863;209.02857457674645;5.244474134527214;0.0069959982775799475;0.6834436629936306;[RAB21, SEMA6B, OLFM1, CDK5, RUFY3, ABL1, ADNP, RAB11A, PAFAH1B1]
GO:0051156;glucose 6-phosphate metabolic process;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;72.82688802824934;6.686031174322154;0.0024374504023614934;0.6321649570480018;[RPIA, HK3, GPI, G6PC3]
GO:0006427;histidyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;9.083926447120524;0.006875708083302461;0.8969813732811862;[HARS]
GO:0006309;apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;682.1166149099336;7.004484905440688;0.022829829235937554;0.7544503089863854;[FEN1, DFFA, ENDOG, CASP3, KPNB1]
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;5.734022359845919;0.001941286215318787;0.64415753539903;[HIST1H2BJ, SPHK1, MADD, RIPK1, RFFL, TRIM32]
GO:1901385;regulation of voltage-gated calcium channel activity;10.0;0.811012628672052;0.8207473261969463;9.474373572664863;230.24677907309362;6.139487467954083;0.007706152486928402;0.7292146864874571;[AHNAK, NPPA, CRHR1]
GO:0006120;mitochondrial electron transport, NADH to ubiquinone;6.0;1.0;0.8231203125901445;9.628524252492122;32.64917349834284;5.9928839937622085;0.0010927384546410499;0.6295966787287501;[NDUFA7, NDUFB7, NDUFS8, NDUFB10, NDUFS7, NDUFS6, NDUFA10, COQ9]
GO:1904531;positive regulation of actin filament binding;7.0;1.0;0.8509193652572005;9.628524252492122;61.43207151545733;9.777073627680469;0.002056076148347417;0.8509193652572005;[ABL1]
GO:1903200;positive regulation of L-dopa decarboxylase activity;6.0;1.0;0.8231203125901445;9.628524252492122;45.489970642623966;9.777073627680469;0.0015225083790929863;0.8231203125901445;[PARK7]
GO:0006123;mitochondrial electron transport, cytochrome c to oxygen;8.0;1.0;0.875;9.628524252492122;66.39695928536078;6.943860283624253;0.0022222464738971865;0.7301093378270707;[COX15, COX4I1, COX5B, COX6A1]
GO:0006486;protein glycosylation;7.0;0.6181399273706679;0.6599893289425345;8.590536585640447;174.0766208890209;4.3090134865453384;0.005826187842367879;0.5712825153487487;[GALNT12, DPAGT1, GALNT11, DERL3, FUT11, RPN1, TRAK1, GALNT10, FUT4, FUT8, PGM3, MGAT3, ST6GAL1, SDF2L1, PMM1, SLC35C2, COG3, SLC35C1, PMM2, SYVN1, ALG2, DOLK, ALG1, DPM3, TMEM115, DOLPP1, MGAT4B, STT3A, MAN1B1, B4GALT7]
GO:0006487;protein N-linked glycosylation;8.0;0.7980440201809971;0.7740220100904985;9.34084218004034;176.5615275388073;5.500407508664414;0.005909355431665436;0.6562910957882058;[DPAGT1, ST6GAL1, PMM1, DERL3, RPN1, PMM2, SYVN1, FUT8, DOLPP1, MGAT4B, STT3A, PGM3, MGAT3, B4GALT7]
GO:0008543;fibroblast growth factor receptor signaling pathway;8.0;0.7090535922965819;0.729526796148291;8.567652291806858;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[SETX, TIAL1, PTBP1, POLR2B, POLR2G, SHCBP1]
GO:0006000;fructose metabolic process;6.0;0.7980440201809971;0.722142322680643;9.0689084645567;34.676020684410545;7.069023426578259;0.0011605752059146955;0.6846304993685643;[ALDOC, ALDOA]
GO:1902236;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;830.7594506111926;6.832634648514029;0.02780477117699164;0.7646622655359331;[CREB3, XBP1, WFS1, SYVN1, HYOU1, PARK7]
GO:0006122;mitochondrial electron transport, ubiquinol to cytochrome c;6.0;1.0;0.8231203125901445;9.628524252492122;32.64917349834284;7.138016298065211;0.0010927384546410499;0.6881587980249038;[UQCRQ, PMPCB, CYC1]
GO:1990051;activation of protein kinase C activity;12.0;1.0;0.9481203125901445;9.628524252492122;1099.1709144601095;9.083926447120524;0.03678826131738048;0.9126727335416687;[ABL1]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[RPS9, WDR37, DDX27, RPS7, POP4, SUV39H1, WDR18, EIF4A3, HEATR1, NOLC1, NAT10, IMP4, WDR43, BYSL, RRP9, RPS15, BOP1, LAS1L, RPL7L1, PES1, MRTO4, EXOSC3]
GO:0006006;glucose metabolic process;6.0;0.7090535922965819;0.6776471087384355;8.572471578242808;34.676020684410545;5.040875179285974;0.0011605752059146955;0.5809109036834981;[GPI, CRTC2, TPI1, IGFBP5, ADPGK, DCXR, BPGM, PER2, NISCH, HK3, G6PC3, ALDH5A1, FABP5, SLC25A10, ALDOC, ALDOA]
GO:0006488;dolichol-linked oligosaccharide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;80.91159753301743;7.069023426578259;0.00270803835371991;0.6846304993685643;[DPAGT1, ALG9, ALG14, ALG2, ALG1]
GO:0042732;D-xylose metabolic process;6.0;0.8436909121759173;0.7449657686781032;9.405380701177911;34.319345740475256;8.67846133901236;0.0011486376165277907;0.7669372290569613;[DCXR]
GO:0006489;dolichyl diphosphate biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;346.04394917679554;8.16763571524637;0.011581779559612143;0.7686126355688037;[DPAGT1, DOLPP1, DOLK]
GO:0051444;negative regulation of ubiquitin-protein transferase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;660.9612418427423;7.004484905440688;0.022121777937978333;0.7906386361357586;[DTX3L, RPS7, ABL1, FBXO5, PARK7, MAD2L1]
GO:1990046;stress-induced mitochondrial fusion;6.0;1.0;0.8231203125901445;9.628524252492122;89.84934888188366;9.777073627680469;0.0030071768479124736;0.8231203125901445;[STOML2]
GO:0072383;plus-end-directed vesicle transport along microtubule;9.0;0.9326813400603323;0.8625812952104552;9.584072489921288;265.6185688795062;7.8311634786251565;0.00889001445920495;0.7967266896635242;[KIF3B, KIF23]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[ERN1, EIF2B4, XBP1, ENDOG, GPAM, SIN3A, SERPINF1, CASP3, THBS1, AACS, NME1]
GO:0051443;positive regulation of ubiquitin-protein transferase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;659.8486212060837;6.280566066213989;0.022084539526562936;0.7536173930320365;[FZR1, TRIB3, MASTL, UBE2L3]
GO:0035914;skeletal muscle cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.845247994956144;7.050676185779127E-4;0.5489262542938873;[BTG2, MAFF, MED20, SOX8, EMD]
GO:0097202;activation of cysteine-type endopeptidase activity;12.0;1.0;0.9481203125901445;9.628524252492122;669.1123145181327;7.212124270218933;0.0223945870049345;0.8169486831672182;[CYFIP2, PERP]
GO:0010977;negative regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;494.1264199049594;4.793467005972133;0.016537966589312465;0.6413787507847162;[SEMA6B, GAK, CDK5, GFI1, RUFY3, PAQR3, CIB1, THOC2, LRIG2, FKBP4, PAFAH1B1, ZNF365]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[WDR1, VPS33A, CASP3, EP300, CIB1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[USP34, KLHL12, APCDD1, GNG2, GNAT2, MYC, AP2S1, DVL3, MARK2, DACT1, TLE4, CSNK2A1, UBE2B, RYK, SENP2, DDB1, SFRP1, CCNE1, SDC1, TAX1BP3, CALM1, MET, CSNK1G2, TNRC6A, CSNK1G1]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[ACTR2, TMEM30A, SERPINF1, TRAK1, LRP8, RAB11A, NME1, RAB21, SETX, NCKIPSD, FES, RUFY3, CAPRIN1, DVL3, CAMK1, ADNP, SCARF1, MARK2, PAFAH1B1, EZH2]
GO:0030100;regulation of endocytosis;6.0;0.5902001590945054;0.6182203921373972;8.152617732682543;44.90533409728707;4.321752512322768;0.0015029411200592913;0.5441349370523758;[SCARB1, CD151, MCTP1, SIRPG, STON1, WASL, C2, RAB21, C3, ABR, ATXN2, RAB20, AP2S1, ABL1, NCKAP1L, CSK, CCL19, SH3GL1, ATG5, FCER1G, TOR1A, ANGPT1, ITGA2, CAV1, ARFGAP1, BCR, RUFY1, SYNJ1, SNX17, PTX3, DOCK2, SMAP1]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[ITGA2, RCC2, TAOK2]
GO:0051568;histone H3-K4 methylation;11.0;0.8653626801206646;0.8651102923899945;9.53008417967887;767.5947827162904;6.250713103064308;0.02569070658705971;0.7520907111082569;[SETD3, PAXIP1, RBBP5, ARID4A, RLF]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[CCNB1, RAD51C, SIN3A, RCC2, CDC7, RAB11A, CDC25A]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[HDAC3, DTX3L, BAG3, TPR, EIF2AK3, PARK7, ECT2, TMEM173, GTSE1]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[BBS2, SPAG16, ACTR2, GALNT11, SEPT11, ONECUT2, IFT122, FNBP1L, WDR34, DYNLL2, TMEM138, RFX4, CENPJ, TMEM107, NEK1, CCDC65, SNAP29, CLUAP1]
GO:0038189;neuropilin signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;26.50247477320489;8.390779266560578;8.87013979980389E-4;0.7522251544931926;[ABL1]
GO:0006013;mannose metabolic process;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;34.676020684410545;7.474488534686424;0.0011605752059146955;0.7053660038532718;[PMM1, MAN2B2, PMM2, MAN2B1]
GO:0007224;smoothened signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;5.528578385631111;8.87013979980389E-4;0.6058520683365068;[NSDHL, CENPJ, IFT122, PKD2L1]
GO:0007100;mitotic centrosome separation;4.0;1.0;0.75;9.628524252492122;26.82333357677892;7.9853141584524145;8.977528353818361E-4;0.6583693374183408;[KIF3B, NUP62]
GO:0042743;hydrogen peroxide metabolic process;5.0;0.8259837884571596;0.7032329060895001;9.310070521373587;65.97212718490212;6.139487467954083;0.0022080277258189032;0.6042146864874571;[GPX3, PRDX1, PARK7]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[TCERG1, ZNF175, RPL3, RNH1, GFI1, EIF4A3, IKZF1, IKZF2, RPS15, RPS6KA5, MYC, SAP130, DPF2, TRIM24, SOX8, DIP2A, SOX6, ZNF282, SLC35C2, SFMBT2, SERPINF1, HCFC2, SND1, RUNX2, EID1, SFRP1, XRN1, HOXB4, TRIB3, RPL29, FOXG1, MEPCE, GLG1, MTDH, FXR1, HIVEP1, HESX1, A2M, BBS2, CREBBP, XRCC6, ZNF263, XRCC5, H3F3A, EIF2AK3, QARS, PKIA, DCP1A, ZNF136, EZH2, CPEB4, CDKN1C, HBS1L, BTG2, CDKN1A, SMG1, TCF25, SUV39H1, OTUD7B, BRCA1, SMG5, NIPBL, C1QBP, CIC, JARID2, HRAS, HAVCR2, UPF2, ZNF485, UPF1, TSC22D4, HELLS, SIRT2, NME1, NCOR2, NCOR1, NFX1, PTRH2, MTF2, DEPDC1, DCP2, ZNF350, RELA, ARNTL, PPP2CA, BCLAF1, RXRA, EXOSC3, DCPS, RPL19, YTHDF3, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, LIMS1, NAB1, GMNN, ARID4A, UBP1, CASC3, PARK7, UBE2Z, YY1, EIF4ENIF1, WWC3, EP300, ZNF564, TLE4, RPS9, IGFBP5, RPS7, ZBTB32, SARS, ERN1, OLFM1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, MRTO4, TIMELESS, ADNP, PPID, MAX, SUPT6H, BCL2L12, CCNB1, NLRP7, BAG3, TPR, SUDS3, BPTF, TFAP2A, PRNP, DR1, UBE2I, WFS1, NONO, CAV1, CNOT10, LSM5, EIF2S1, NFKB1, CDK9, CNOT4, CNOT6, PAN3, CNOT7, CDK5, CNOT1, CAPRIN1, SP3, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, SKIV2L, CNOT8, PHF19, USP36, CIITA, YWHAB, PTPN22, FLCN, PTBP1, SIN3A, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, PEG3, RFC1, ARID1A, ZFP90, DUSP22, RBL1, TFDP2, LCOR, ETF1, EIF4E2, MCPH1, HDAC3, HDAC1, NLRC4, LRP8, THBS1, U2AF2, DNAJB5, TP53INP1, POLR2G, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, RNF20, RPL23A, TAF7, TNRC6A]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[CSTA, CASP3]
GO:0032757;positive regulation of interleukin-8 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.948432231191374;0.002183412136085803;0.6273234135236593;[RIPK1, PARK7, CD244]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[CASP3, SP3, ATPIF1, CEBPG, KIT, ACIN1, IKZF1, NFE2L1]
GO:0010867;positive regulation of triglyceride biosynthetic process;8.0;1.0;0.875;9.628524252492122;585.9051526913918;7.292166977892469;0.019609718180177402;0.747921758369865;[SCARB1]
GO:0016042;lipid catabolic process;4.0;0.5127202928476964;0.5063601464238482;6.883086519318291;43.14795622097559;4.114113147544524;0.0014441232640765526;0.4603959376912539;[SCARB1, ECHS1, ABCD3, HSD17B4, ETFA, ETFB, GBA2, PLD3, SGPL1, CPT2, SCARF1, HIBCH, HSD3B7, PLA2G12A, ACOT7, SPHK1, DDHD2, SIRT2, GALC, ALDH3A2, BSCL2, ACOX2, FABP5, SNX17, TBL1XR1, PNPLA6, DAGLB, HRASLS, SLC27A2, MGLL, PAFAH1B1]
GO:0051571;positive regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.004484905440688;0.026910571697265715;0.7906386361357586;[PAXIP1, BRCA1]
GO:0010506;regulation of autophagy;6.0;0.6260725219892441;0.6361565735847665;8.273978589686811;43.35793677134884;4.08334148887777;0.001451151124127319;0.5319425862261522;[BECN1, USP36, CALCOCO2, CLEC16A, PTPN22, VPS26B, PARK7, RASIP1, MTDH, FLCN, HERC1, TP53INP2, CASP3, TP53INP1, ATP6V0A2, ABL1, EP300, XBP1, ATPIF1, SIRT2, ERN1, CDK5, CHMP4B, RAB3GAP2, MET, EIF4G2, RAB3GAP1, EXOC1]
GO:0030330;DNA damage response, signal transduction by p53 class mediator;7.0;0.8933024483968273;0.7975705894556142;9.4949928598676;85.94894796857642;5.407625775213448;0.0028766339394770053;0.627465598881932;[BTG2, CDKN1A, PCNA, PAXIP1, CNOT10, BRCA1, CNOT4, CNOT6, CCNB1, TFDP1, CNOT7, TFDP2, CNOT1, BCL3, CNOT3, CDK2, CASP2, EP300, CNOT8, GTSE1, E2F7, E2F8]
GO:0010501;RNA secondary structure unwinding;7.0;1.0;0.8509193652572005;9.628524252492122;115.0816327851482;5.948432231191374;0.0038516786825735262;0.6551224661907153;[DDX59, DDX27, EIF4A3, DDX23, DDX42, DDX41]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[NFKBIA, SCARB1, CCL5, PTPN22, MTDH]
GO:0018344;protein geranylgeranylation;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;169.3659377599637;7.9853141584524145;0.00566852551737791;0.7833693374183408;[RABGGTA]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[CXCL6, SCARB1, GPI, MCTP1, ONECUT2, DOCK8, ITGB3, KIF14, CIB1, WASL, IGF1R, FLCN, NIPBL, ADORA3, C1QBP, ARHGDIB, CTSH, IL12A, ATP7A, GTSE1, HRAS, CCR2, SEMA6B, PDGFRB, TBCCD1, IGFBP5, ITGA2, SPHK1, SWAP70, SERPINF1, RHOC, PTP4A1, BCR, NISCH, CREB3, SFRP1, KARS, IL23A, RUFY3, KIT, EPHA1, MAPRE1, MET, HBEGF, CD151, ROCK2, CD99L2, THBS1, CORO1A, ABR, RRAS, TBXA2R, CCL5, TP53INP1, LMNA, ABL1, NCKAP1L, LRIG2, CCL19, RFFL, MTA2, CLASP1, RNF20, MAP3K3, STARD13, XBP1, ANGPT1, CCL20, RCC2, IDH2, RAB11A, VIL1, IL6, P2RX4, CDK5, SP1, FGFR1OP, TEK, TRIM32]
GO:0051457;maintenance of protein location in nucleus;7.0;0.811012628672052;0.7564256795932265;9.292052015870908;48.00389740763819;6.686031174322154;0.0016066472455308106;0.692843310444282;[CDK5, ARL2BP, BCL3, ARL2, PARK7]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[POLE4, DR1, CRTC2, IRF4, BRPF3, POLE3]
GO:0006463;steroid hormone receptor complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;44.51706700895919;9.777073627680469;0.0014899461700306506;0.8231203125901445;[FKBP4]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[OXTR, MAML1, CCNH, IL5RA, BUB1B, STK19, IGF1R, RPS6KA4, RPS6KA5, RPS6KA2, MYC, CFL1, TRIM24, NEK1, EPHB4, PDGFRB, CSNK2A1, PAQR3, VRK1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, CCNE1, TRIB3, EPHA1, CSNK1G2, CSNK1G1, PKMYT1, RASGRP4, STK3, NUAK1, CCNB1, STK35, STK38, ABL1, STK38L, MBP, RIPK1, MARK2, EIF2AK3, CDC7, ERLIN2, CLK4, EIF2S1, CLK3, NFKB1, SETX, CLK1, CDK9, PAN3, CDK6, CDK5, PTPRA, FES, CDK2, FGFR1OP, CALM1, MNAT1, SMG1, FASTKD1, MAST3, YWHAB, AKAP13, ZMYM2, PBK, CTSH, HRAS, DUSP5, MAP4K2, KSR1, CAD, OXSR1, MASTL, GFRA2, SPTB, CIT, GAK, ITPKB, PDIK1L, KIT, FASTKD5, PIK3C3, MET, HBEGF, ROCK2, GPS1, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, ANGPT1, GTF2H4, P2RX7, SNRK, WEE1, TNIP2, CAMK4, TAOK2, CCM2, KRAS, CAMK1, TEK]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[CDKN1C, ERRFI1, CDKN1A, GPS1, CIB1, PTPN22, PARK7, DUSP14, IGF1R, PPP2CA, CASP3, NUP62, STK38, ABL1, DUSP5, CDKN2C, CAV1, PAQR3, DUSP22, SFRP1, CDK6, QARS, GNAQ, PKIA, TAF7, FGFR1OP, CRIPAK, TRIB3, EPHA1, CHMP6]
GO:0042754;negative regulation of circadian rhythm;4.0;0.8259837884571596;0.6629918942285797;9.040737587590003;21.64841646219066;7.069023426578259;7.245530166796041E-4;0.6115101867784198;[PER2, SIN3A, SUV39H1]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[ERRFI1, XBP1, SP1, MARS, PPAT, RAB13, TRIB3, RAB8B]
GO:0051583;dopamine uptake involved in synaptic transmission;9.0;1.0;0.896240625180289;9.628524252492122;254.03495274861447;7.9853141584524145;0.0085023212518817;0.8046099625986299;[PARK7]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[SERPINA3, CSTB, SERPINB1, CSTA, ITIH2, CSNK2A1, AMBP, SERPINF1, SERPINA10, PLAUR, TNFRSF10B, TNFRSF10A, NLRC4, PARK7, UBE2Z, THBS1, SERPINB6, AQP1, VIL1, C3, BCL2L12, NLRP7, RFFL, A2M]
GO:0030200;heparan sulfate proteoglycan catabolic process;8.0;1.0;0.875;9.628524252492122;576.1643235394821;8.67846133901236;0.019283701394640074;0.8188169164668168;[SGSH]
GO:0060193;positive regulation of lipase activity;6.0;0.7671156992804218;0.7066781622303554;9.186691500213083;50.03060230748208;5.587418885654044;0.001674479234612594;0.6088611742440427;[PDGFRB, GNAQ, CCL5, GPR55, KIT, NMUR1, RHOC, HRAS, RASGRP4]
GO:0032981;mitochondrial respiratory chain complex I assembly;7.0;1.0;0.8509193652572005;9.628524252492122;91.11357555959822;5.618190544320798;0.003049489377085438;0.638233890966345;[NDUFA7, NDUFB7, NDUFS8, NDUFA11, NDUFB10, NDUFS7, NDUFS6, NUBPL, NDUFA10, BCS1L, FOXRED1]
GO:1903351;cellular response to dopamine;8.0;1.0;0.875;9.628524252492122;545.6259493406901;7.138016298065211;0.018261609492958953;0.7400384854347593;[SIN3A, ABL1]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[DDB1, RFC5, RFC3, WDR48, RFC4, PCNA, UBE2B, RFC1, PNKP, NEK1]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANKRD17, MEPCE]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, TRIB3, ASF1B, ZNF276, ZNF395, ZNF394, PAXIP1, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, HIVEP2, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, ZNF136, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, TCF25, SUV39H1, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, JARID2, ZNF485, TSC22D4, HELLS, COMMD3, BAZ1A, COMMD1, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF350, HEATR1, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, TCEAL3, GPBP1L1, ZNF101, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, YEATS4, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, SARS, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, TMEM18, MNAT1, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, PHTF2, CIITA, ONECUT2, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, KLF11, KLF12, TBP, KLF13, RFC1, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, LCOR, ZNF511, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, RBBP7, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3B, POLR3C, TNIP2, POLR3E, TAF7, MNDA, TAF5]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[DUSP5, EYA2, SSU72, DUSP28, PTPN22, PPP2R5D, SSH3, CDC25A, PPM1G, DUSP14, PPP1CB, PTP4A1, PPP2CA, DUSP22, PPP1CC, DUSP23, PPP6C, MINPP1, PDPR, PTPRA, CTDSP2, SBF1]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[ZNF175, NUP107, MAML1, GPATCH3, ELK1, MYC, ZXDC, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, HCFC2, SND1, MED6, EID1, EWSR1, RFX4, HOXB4, ASF1B, ZNF276, ZNF395, ZNF394, MEPCE, ZNF20, CDCA7, NOLC1, ZNF25, MTDH, HSPH1, RAD21, HESX1, HOXC4, ZNF264, ZNF143, CREBBP, ZNF263, ZNF260, H3F3A, PBX3, EIF2AK3, ERLIN2, ZNF35, FLI1, SOX30, SETX, QARS, PKIA, ZNF30, ZNF136, EZH2, CDKN1C, SETD5, BTG2, CDKN1A, SETD3, ELL, ZNF250, TCF25, ATF7IP2, HOXC13, ZNF45, WDR43, NIPBL, CHAF1B, CIC, JARID2, HAVCR2, ZNF485, HELLS, SPHK1, BAZ1A, TMEM173, MED29, SIRT2, MED28, GNL3, NCOR2, NCOR1, MTF2, MED20, ZNF350, ZNF69, BCLAF1, UBN1, ZNF101, ZNF462, EGLN2, ATAD2, GTF2H4, CENPF, NFIA, NFIB, NFIC, PSMC1, ZNF696, MIXL1, ZNF212, LIMS1, ZNF331, NCF1, NAB1, GMNN, UBP1, RORA, YEATS4, PARK7, YY1, ADORA3, ZNF207, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, SARS, PIAS2, ARMCX3, ILF3, ADNP, ZNF550, MAX, RLF, GTF2E2, BCL2L12, BAG3, TPR, ZNF549, ZNF548, ABL1, DVL3, ZNF544, TRAPPC2, ZBTB17, DR1, WFS1, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, MNAT1, ZNF532, ZNF410, NFE2L1, CIITA, ONECUT2, ITGB2, LBH, SIN3A, ZNF407, ZNF768, ZNF525, ZNF524, ZNF766, HIF1AN, PEG3, DTX3L, RFC1, ZFP91, ARNT, ZFP90, DUSP22, TFDP1, ZNF519, TFDP2, LCOR, ZNF511, MET, ZNF630, GTF3C1, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, NLRC4, LRP8, RBBP5, DNAJB5, TP53INP2, TP53INP1, ASCC3, ZNF622, RBBP7, E2F7, E2F8, IRX1, TBX1, RNF20, FBXL15, POLR3C, MNDA, TRIM32, TCERG1, CCNH, GFI1, IKZF1, IKZF2, UBE2L3, TIAL1, RPS6KA4, RPS6KA5, SAP130, DPF2, TRIM24, SOX8, FBXO5, SOX6, SFMBT2, FLT3LG, RUNX2, THAP6, SFRP1, TWSG1, KARS, IL23A, BOLA3, TRIM14, TRIB3, PAXIP1, FOXG1, COMMD9, HLTF, HIVEP1, SCAP, HIVEP2, XBP1, XRCC6, SETDB1, XRCC5, EAF2, STAG1, GOLGB1, AHCTF1, SUV39H1, OTUD7B, BRCA1, WASL, AATF, ZMYM2, SCML1, C1QBP, HRAS, TSC22D4, SEC13, NCOA6, PRMT3, COMMD3, COMMD1, PPRC1, ZFX, VAV1, TOX4, GAL, NFX1, TFEC, KIT, DEPDC1, MAPRE3, VGLL4, ARHGEF5, PCNA, HEATR1, NEDD8, ZNF2, TRAK1, RELA, ARNTL, PPP2CA, SERTAD3, RXRA, SERTAD2, TCEAL3, GPBP1L1, SCAND1, NFYC, GRHL1, PER2, ITCH, NLRP12, GFI1B, HIST3H2A, TTC5, CAMK4, MARS, CAMK1, CRTC2, CD80, ARID4A, CIB1, UBE3A, WWC3, EP300, SNIP1, SSU72, ERN1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, PPID, CARD11, SUPT6H, AGER, STK3, NLRP2, NLRP3, RIPK1, CYTL1, SUDS3, BPTF, TFAP2A, PRNP, UBE2I, NONO, CAV1, CNOT10, NFKBIA, IL6, ZSCAN2, PHF19, USP36, PHTF2, YWHAB, DDX41, PKD2, CHD1, AFF4, CKS1B, FLCN, NUP62, GATAD1, LRRFIP1, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, BUD31, MKL1, SENP2, SAFB, ARID1A, CREB3, RBL1, SETBP1, ELF4, IRF4, ITGB3BP, MCPH1, TFPT, FAM120B, TAF1A, MTA2, ZNF189, CHURC1, EYA2, ARID3B, DEK, USF2, CD4, TNIP2, TAF7, KRAS, TAF5]
GO:1903599;positive regulation of autophagy of mitochondrion;8.0;0.811012628672052;0.780506314336026;9.50592193039979;380.408269463316;6.8867018697843045;0.012731922433721603;0.7271862538851576;[ATPIF1, PARK7]
GO:0008535;respiratory chain complex IV assembly;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;46.462977158014716;6.599019797332524;0.0015550740315141028;0.6883935445785896;[COX15, BCS1L]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[TCERG1, ZNF175, MAML1, CCNH, GFI1, IKZF1, IKZF2, ELK1, TIAL1, RPS6KA4, RPS6KA5, MYC, SAP130, ZXDC, DPF2, SOX8, SOX6, IER5, IER2, ZNF282, FLT3LG, HCFC2, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, IL23A, RFX4, BOLA3, HOXB4, TRIB3, ZNF276, ZNF395, ZNF394, PAXIP1, FOXG1, MEPCE, ZNF20, ZNF25, MTDH, HSPH1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, ZNF260, PBX3, EAF2, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, ZNF136, EZH2, AHCTF1, BTG2, CDKN1A, SETD3, ELL, ZNF250, TCF25, SUV39H1, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, NIPBL, ZMYM2, C1QBP, CIC, JARID2, HRAS, HAVCR2, ZNF485, TSC22D4, NCOA6, TMEM173, PPRC1, ZFX, SIRT2, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, KIT, ZNF350, NEDD8, ZNF2, TRAK1, ZNF69, RELA, ARNTL, RXRA, TCEAL3, UBN1, ZNF101, ZNF462, EGLN2, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, TTC5, NFIC, PSMC1, CAMK1, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, ARID4A, UBP1, RORA, YEATS4, UBE3A, PARK7, YY1, WWC3, EP300, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, SSU72, ZBTB32, SARS, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BCL2L12, BAG3, TPR, ZNF549, ZNF548, ABL1, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TFAP2A, ZBTB17, DR1, UBE2I, WFS1, NONO, CAV1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, MNAT1, ZNF532, ZNF410, NFE2L1, ZSCAN2, CIITA, ONECUT2, DDX41, PKD2, CHD1, FLCN, SIN3A, ZNF407, GATAD1, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, PEG3, RFC1, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, LCOR, ZNF511, MET, MCPH1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, LRP8, DNAJB5, ZNF622, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, FBXL15, ARID3B, DEK, USF2, TNIP2, TAF7]
GO:0051353;positive regulation of oxidoreductase activity;5.0;0.6873818243518346;0.6339319240368375;8.560683622490766;68.71016387165909;5.905872616772578;0.002299667349651622;0.5922676121338333;[SCARB1, CCS, ABL1, KRAS, PARK7, ATP7A]
GO:0018323;enzyme active site formation via L-cysteine sulfinic acid;10.0;1.0;0.9152410118609203;9.628524252492122;476.6441395001505;9.777073627680469;0.0159528503971944;0.9152410118609203;[PARK7]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, DCLRE1A, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, MUM1, CIB1, BRCA1, PARK7, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, RFC5, UPF1, AQR, RFC3, RFC4, FBXO18, DTX3L, RFC1, NCOA6, PARP2, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, PCNA, PAXIP1, PNKP, GPS1, COPS7B, COPS7A, XPC, UNG, RAD51AP1, TFPT, FZR1, WRN, POLR2B, RAD21, ABL1, RAD54L, POLR2G, USP51, FANCI, POLQ, XRCC6, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, APEX2, CDC7, FANCE, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, NPLOC4, TTC5, UBE2T, POLE2, RFWD3, CDK2, ERCC5, MNAT1]
GO:0030150;protein import into mitochondrial matrix;10.0;1.0;0.9152410118609203;9.628524252492122;478.64673420754235;6.781341354126479;0.01601987543983258;0.7620391240755716;[TOMM40, TIMM44]
GO:0030031;cell projection assembly;4.0;0.6729672293956388;0.5864836146978194;8.124446855715847;35.515967283127445;3.9749552523034066;0.0011886874626708887;0.45327939645711923;[SPAG16, CYFIP2, NCKAP1, GALNT11, ONECUT2, FNBP1L, TMEM107, ABL1, NEK1, NCKAP1L, SNAP29, NEFH, BBS2, ACTR2, SEPT11, IFT122, EMP3, WDR34, DYNLL2, P2RX7, CCDC88A, PARVG, TMEM138, RFX4, CENPJ, KIT, CCDC65, FXYD5, CLUAP1]
GO:0022408;negative regulation of cell-cell adhesion;6.0;0.5806842727486619;0.6134624489644754;7.765305819281922;52.92767189200162;4.7081694254602375;0.0017714415464131104;0.5638963159604501;[PRNP, LAG3, IL4R, CD80, SWAP70, FGG, GLMN, PTPN22, PDCD1LG2, DUSP22, ITCH, TWSG1, CASP3, ABL1, CD9, CTLA4, MBP, FXYD5, HAVCR2]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[OXTR, WBP2, CAV1, UBE3A, THBS1, RELA]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[RFC5, AQR, RFC3, RFC4, PCNA, RFC1, CCNH, GPS1, COPS7B, COPS7A, GTF2H4, DDB1, COPS5, POLR2B, EP300, POLR2G, ERCC5, MNAT1]
GO:0006047;UDP-N-acetylglucosamine metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;163.5767575156466;7.004484905440688;0.0054747668645245785;0.7091290490632969;[DPAGT1, PGM3]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[ERN1, MAP4K2, RIPK1, CCL19, MAPK8IP3]
GO:0008344;adult locomotory behavior;3.0;0.8436909121759173;0.6199657686781032;9.158520623246385;24.575257889458463;5.459585514144159;8.225117652639858E-4;0.47732376968016754;[CSTB, PBX3, CTNS, PARK7, NTSR1, PAFAH1B1, ARCN1]
GO:0007254;JNK cascade;11.0;1.0;0.9324289523296623;9.628524252492122;290.6144555783003;5.926926025970411;0.009726604292176047;0.735532224928036;[MAP4K2, GPS1]
GO:0042255;ribosome assembly;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;107.30488678463786;7.138016298065211;0.0035913979925534566;0.7159578506919597;[C1QBP, NIP7]
GO:0008585;female gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;6.8867018697843045;0.001705743211299806;0.6424272657460779;[SFRP1, NUP107]
GO:0000973;posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery;6.0;1.0;0.8231203125901445;9.628524252492122;21.24116723228514;8.67846133901236;7.10922751455178E-4;0.7669372290569613;[NUP107]
GO:0001942;hair follicle development;4.0;1.0;0.75;9.628524252492122;22.36266381479647;6.166155715036245;7.48458232790436E-4;0.5653374900225189;[NSDHL, HOXC13, APCDD1, RELA]
GO:0032201;telomere maintenance via semi-conservative replication;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;216.32599304453976;6.7325511899570465;0.0072402363064467505;0.719302980950052;[RFC5, UPF1, FEN1, RFC3, POLA2, RFC4, PCNA, RFC1]
GO:0031113;regulation of microtubule polymerization;9.0;0.7980440201809971;0.7952626352707877;9.434368238051164;87.92921841078594;5.9928839937622085;0.0029429118090500655;0.7027169913188946;[FES, ABL1, ARL2, MAPRE1, FKBP4, MET, CLASP1, EML2]
GO:0010899;regulation of phosphatidylcholine catabolic process;9.0;0.9326813400603323;0.8625812952104552;9.567899630675686;138.79941293968457;8.67846133901236;0.0046454914397295296;0.8400575416471059;[SCARB1]
GO:0034982;mitochondrial protein processing;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;185.93579430810107;7.474488534686424;0.006223103704141336;0.7331650565203278;[STOML2, PMPCB]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[FES, ARL2, MAPRE1, MET, CLASP1]
GO:0071934;thiamine transmembrane transport;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;153.8371691668038;8.390779266560578;0.0051487916075492485;0.7522251544931926;[SLC25A19]
GO:0030388;fructose 1,6-bisphosphate metabolic process;5.0;1.0;0.7902410118609202;9.628524252492122;72.82688802824934;7.8311634786251565;0.0024374504023614934;0.6907270763441554;[ALDOC, ALDOA]
GO:0035710;CD4-positive, alpha-beta T cell activation;7.0;0.7369933605727446;0.7194160455435727;8.874752450115741;23.590520244074952;6.518977089658987;7.895534824793431E-4;0.6843001567857983;[STOML2, BCL3, RORA, IL12A, ATP7A]
GO:0031115;negative regulation of microtubule polymerization;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;405.4514152206468;7.292166977892469;0.013570093984851534;0.7881627702307852;[MAPRE1, FKBP4, EML2]
GO:0007021;tubulin complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;44.51706700895919;7.8311634786251565;0.0014899461700306506;0.7236063770733796;[ARL2]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[RPL3, NUP107, CCNH, PKD2L1, IKZF1, GLS, PSMD8, RPS15, PSMD4, TFG, PPAT, MYC, FBXO5, TSPYL1, COG4, BCS1L, PRKAB1, MED6, NUP93, COX7A2L, KCTD10, KCTD14, CD2BP2, TSPYL6, ASF1B, EPB41, XPC, DHX30, SPAST, RNF213, TSPAN4, ATP6V0A2, NCKAP1L, S100A10, VASP, CREBBP, XRCC6, H3F3A, EIF2AK3, PILRB, RPL3L, SETX, COL1A2, AHCTF1, GPAA1, SRP54, CLTA, WASL, CLYBL, CHAF1B, CHAF1A, SH3PXD2A, C1QBP, TMED2, HRAS, ATPAF2, SEC13, KCND1, FCER1G, ATPIF1, DDB1, GCHFR, ALDH5A1, RAD51C, VAMP4, ALDOA, SLU7, AHNAK, NIP7, KCNA3, HSD17B8, TM9SF4, NAPG, HLA-DMA, RXRA, HLA-DMB, UBN1, AP2S1, STX5, BID, NUBPL, WDR18, GTF2H4, CENPE, BOP1, CENPF, CENPH, CENPJ, CENPK, CENPL, CENPP, DPAGT1, CRTC2, DGKD, NDUFA11, NCF1, NDUFA10, GMNN, TMEM141, IPO4, IGF1R, ZNF207, EP300, OIP5, KNTC1, TLE4, TRAPPC2L, KCTD5, TBC1D20, PRPF3, MRTO4, SNRPG, CHMP4B, FKBP4, PPID, HIST1H2BC, NDUFB10, TUBGCP2, YTHDC1, MAX, COX15, ARL2, KLHL12, ACACA, ATXN2, CCNB1, NLRP3, RIPK1, ECT2, TRAPPC2, TRAPPC3, PRNP, CPSF6, TOR1A, CAV1, NUP153, EIF2S1, VIL1, CNOT7, SYNJ1, ARPC2, MNAT1, YWHAB, USP39, PKD2, PPP6C, NUP62, SNAP29, RBM5, FGA, PDCD6IP, TBP, GPX3, DCXR, FGG, CKAP5, RABGGTA, TAPBP, NDUFS8, NDUFS7, TRAPPC6B, NDUFS6, POLR1E, CHMP6, ITGB3BP, MCM2, COLEC12, STOML2, NDUFB7, HIST1H2BO, HIST1H2BJ, HDAC1, DDX23, ITLN1, NLRC4, FOXRED1, RBBP5, CCL5, RBBP7, POLQ, RRM1, NDUFA7, SEPT11, ANGPT1, RPL23A, P2RX7, MARCKS, RAD51, P2RX4, IMPDH2, POLE3, TAF7, CCDC65, ERCC5, TEK, SEC24C]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[DDB1, RFC5, RFC3, RFC4, PCNA, RFC1, ERCC5, GTF2H4]
GO:0006172;ADP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;8649.513914728412;9.083926447120524;0.2894914466688205;0.8969813732811862;[AK2]
GO:0006293;nucleotide-excision repair, preincision complex stabilization;7.0;1.0;0.8509193652572005;9.628524252492122;108.6814430544141;6.7325511899570465;0.003637470092082656;0.6952223462072524;[DDB1, ERCC5, GTF2H4]
GO:0006294;nucleotide-excision repair, preincision complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;65.90281547005735;6.409777797693995;0.002205707925099542;0.6787156999164222;[DDB1, CCNH, ERCC5, XPC, MNAT1, GTF2H4]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[RAB3B, NCKAP1, CDKN1A, ROCK2, ARHGAP1, PARK7, RASGRP2, RAB21, RAB43, RAP1B, RHOT2, RHOT1, RAB20, RRAS, RAB40C, ARHGDIB, CFL1, RAB28, RAB6A, HRAS, RAB8B, KSR1, SETDB1, RAB27B, RHOC, RAB11A, NISCH, COL1A2, ALS2, RAB13, CDK2, RAB18, ELMO1, TAX1BP3, KRAS, ARHGEF1, KPNB1]
GO:0006298;mismatch repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;6.375876246018314;0.006126539929698291;0.701062607729944;[PCNA, MSH3, EXO1, ABL1, XPC]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[RHOT2, RHOT1, COL1A2, ROCK2, ARHGDIB, CFL1, ARHGAP1, TAX1BP3, ARHGEF1, RHOC]
GO:0032438;melanosome organization;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;22.01435712052086;6.558197802812269;7.368007211887049E-4;0.6585068532133508;[AP1G1, LYST, AP1M1]
GO:0043484;regulation of RNA splicing;7.0;0.7671156992804218;0.7344772148974115;9.34084218004034;89.9604162809808;4.901876304479318;0.0030108941738060855;0.601601547428833;[WTAP, AHNAK, YTHDC1, CLK4, CLK3, SETX, CLK1, ERN1, RBM3, PTBP1, SON, U2AF2, C1QBP, ZNF326, RBM5]
GO:0070830;bicellular tight junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;6.280566066213989;0.001878987018571015;0.6443087532925187;[PDCD6IP, RAB13, ARL2, ECT2, MTDH]
GO:1903094;negative regulation of protein K48-linked deubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;1041.1830685525395;9.083926447120524;0.034847460300527246;0.8969813732811862;[PARK7]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[ZFAND2A, CAV1, UBQLN1, RAD23A, TRIB3, SIRT2]
GO:0032434;regulation of proteasomal ubiquitin-dependent protein catabolic process;10.0;0.7307253602413294;0.7806036919815851;9.240758721483358;451.96383804573134;4.964889272308052;0.015126822918344251;0.6691456801377169;[ZFAND2A, CAV1, GLMN, CLEC16A, UBQLN1, PBK, RAD23A, TRIB3, PARK7, COMMD1, SIRT2]
GO:0032435;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8436909121759173;0.8542744084176208;9.523163736834295;3784.4609618058316;6.343086423195323;0.1266625025978984;0.7568146869955557;[CLEC16A, PBK, PARK7]
GO:0070508;cholesterol import;8.0;1.0;0.875;9.628524252492122;77.49126092049113;7.9853141584524145;0.0025935627654017587;0.7833693374183408;[SCARB1]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[FEN1, PNKP, MCM10, BRCA1, POLB, CHAF1B, WRN, CHAF1A, EXO1, SIN3A, RBBP7, RFC5, UPF1, POLQ, RRM1, RFC3, DUT, RFC4, RFC1, NCOA6, DONSON, WRNIP1, CDC7, BAZ1A, CCDC88A, POLA2, NFIA, NFIB, NFIC, POLE2, CDK2, POLE3, CDK2AP1, MCM5, MCM6, MCM2]
GO:0000715;nucleotide-excision repair, DNA damage recognition;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.24116723228514;6.641579411751319;7.10922751455178E-4;0.6298916918429109;[DDB1, COPS5, GPS1, COPS7B, COPS7A, XPC]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[HSD3B7, STARD3, SCARB1, ERLIN2, ACLY, SQLE, EBP, NSDHL, RXRA, SNX17, FDXR, SCAP, APOL1, SCARF1, NFE2L1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, MAP3K3, UBE2I, SLC20A1, ZDHHC13, TNFRSF10B, RHOC, RELA, MTDH, AKAP13, CD4, TFG, TNIP2, UBD, NUP62, ABL1, RIPK1, CCL19, ECT2, TRIM32, CARD11, TMED4]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[CDKN1C, TOP2B, BTG2, CDKN1A, ZWILCH, CCNF, GMNN, BUB1B, BRCA1, PKD2, GPR132, RPS6KA2, MYC, CASP3, ZNF207, CASP2, EP300, IL12A, KNTC1, FBXO5, TOPBP1, GTSE1, HRAS, DACT1, TIPIN, PRKAB1, ERN1, TFDP1, RBL1, ESPL1, TFDP2, CTDSP2, TIMELESS, PRR11, MCPH1, PCNA, TP53I13, MAX, XPC, THBS1, PPM1G, CCNB1, FZR1, RAD21, TPR, TP53INP1, TP53BP2, ABL1, RBBP7, E2F7, E2F8, FANCI, ZBTB17, PRNP, CDKN2C, INTS3, DONSON, MAD2L1BP, CNOT10, CDC7, ZWINT, CDK9, CNOT4, CNOT6, CENPF, WEE1, STAG2, RAD51, CDK6, CNOT7, FAP, CDK5, CNOT1, RFWD3, CNOT3, TAOK2, CDK2, INTS7, CNOT8, EIF4G2, EZH2, MAD2L1]
GO:0006267;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;77.92043580405796;8.67846133901236;0.0026079268625224215;0.8400575416471059;[WDR18]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP2, NCKIPSD, NCKAP1, ACTR2, ARPC2, WIPF2, ARPC1A, ELMO1, ABL1, NCKAP1L, WASL, VAV1]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[NLRP12, ABL1, OTUD7B, RORA, RIPK1, TANK]
GO:0046632;alpha-beta T cell differentiation;7.0;0.7140352122741334;0.7079369713942671;9.04870575723918;90.58502354652471;6.166155715036245;0.0030317992168737967;0.6662568552797195;[BCL3, ABL1, RORA, ATP7A]
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;7.0;1.0;0.8509193652572005;9.628524252492122;76.30875120206336;6.375876246018314;0.0025539852293156346;0.6769819729871445;[BAG3, EYA2, CASP3, MKNK2, CASP2]
GO:0006027;glycosaminoglycan catabolic process;6.0;0.7866048967936545;0.7164227609869718;9.245532000236016;234.16675596998346;5.618190544320798;0.00783735058591714;0.610434838299289;[SDC1, GUSB, SGSH]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[FUT8, FCER1G, ITGB4, ITGB3, ITGA2, RCC2, ITGB2, ABL1, NEDD9, CCM2, ITGAE, VAV1]
GO:0001922;B-1 B cell homeostasis;8.0;1.0;0.875;9.628524252492122;22.00128503895464;8.67846133901236;7.363632103827933E-4;0.8188169164668168;[ABL1]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[CXCL6, CIITA, CDKN1A, CD80, ITGB2, IL5RA, CIB1, RORA, IL27, RPS6KA4, RPS6KA5, MYC, CASP3, CFL1, IL12A, CCR2, HLA-DPA1, IFNAR2, IL4R, FLT3LG, HLA-A, HLA-F, YWHAZ, VAV1, KARS, IL23A, IRF4, KIT, PSME2, LCP1, EBI3, LRP8, ADIPOR2, RELA, IL22RA2, HSP90B1, RAP1B, CCL5, IL21R, NCAM1, RIPK1, CCL19, IL12RB1, HLA-DQA1, CCR10, BBS2, MAP3K3, CCL20, CD70, TNFRSF10B, TNFRSF10A, NFKB1, NFKBIA, CD4, IL6, COL1A2, TNIP2, HLA-DPB1, SDC1, KRAS, HLA-DRB3, LIMS1]
GO:0016197;endosomal transport;5.0;0.7090535922965819;0.6447678080092112;8.817594036275793;47.18803257139101;4.463867648638682;0.0015793409836922997;0.5185234110033771;[TMEM87A, GRIPAP1, GOSR1, CLEC16A, ARHGAP1, ZFYVE21, VPS26B, LYST, RAB11A, BAIAP3, ALS2, SNX17, RAB13, VPS52, STX5, CHMP4B, VPS54, CHMP6, RAB6A, VPS16, PLEKHJ1]
GO:0032543;mitochondrial translation;8.0;1.0;0.875;9.628524252492122;403.65714686199146;6.193554689224359;0.013510041437624024;0.6917386748366816;[NDUFA7, MRPS16, MRPS24, MRPS18B, MRPS18A, HARS]
GO:0019348;dolichol metabolic process;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;70.08763053353812;8.16763571524637;0.0023457699191852016;0.7686126355688037;[DPAGT1]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[POLA2, CCNE2, CCNE1, GINS4, MCM10, CDC7, MCM5, TOPBP1, MCM6, MCM2]
GO:0070979;protein K11-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;6.375876246018314;0.00527474598481953;0.7584915600596062;[ANAPC13, FZR1, UBE2B, UBE2T, CDC26, CDC16, ANAPC5, ANAPC11, UBE2L3]
GO:0007000;nucleolus organization;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;20.915744831851537;7.8311634786251565;7.000311565738116E-4;0.6907270763441554;[USP36, PES1, NOLC1]
GO:0031571;mitotic G1 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;856.0185997856339;7.474488534686424;0.0286501721681018;0.8146746435927894;[RFWD3, CDK2]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[POLQ, FEN1, WDR48, FBXO18, GINS4, NSMCE2, CDC7, BRCA1, YY1, RAD51AP1, NIPBL, WRN, RAD51C, RAD51, RFWD3, RAD54L]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[FES, ABL1, CSK, IGF1R]
GO:2000825;positive regulation of androgen receptor activity;12.0;1.0;0.9481203125901445;9.628524252492122;1282.7688761636532;8.390779266560578;0.04293311986816003;0.8772251544931927;[BUD31, PARK7]
GO:0010886;positive regulation of cholesterol storage;7.0;1.0;0.8509193652572005;9.628524252492122;69.4460343959197;7.8311634786251565;0.002324296273858149;0.7514054297404357;[SCARB1]
GO:0070972;protein localization to endoplasmic reticulum;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;32.77360880529348;5.014899692882714;0.001096903192380182;0.5795825161008517;[RPS9, RPL3, PMM1, RPS7, PMM2, SRP54, RPL23A, UBAC2, RPS15, SPCS2, CHMP4B, RAB3GAP2, RPL29, RAB3GAP1, RPL19]
GO:0033864;positive regulation of NAD(P)H oxidase activity;6.0;1.0;0.8231203125901445;9.628524252492122;95.10874301741602;7.8311634786251565;0.0031832040364813217;0.7236063770733796;[PARK7]
GO:0010762;regulation of fibroblast migration;7.0;0.8259837884571596;0.7639112594857803;9.427853557029971;40.03709713961528;6.481236761676141;0.0013400056102148314;0.6823701146576509;[RCC2, RFFL, MTA2, THBS1]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1C, PRNP, CDKN1A, CDKN2C, PKD2, THBS1, PRKAB1, PPM1G, ERN1, CDK6, FAP, MYC, TP53INP1, ABL1, IL12A, PRR11, HRAS, EIF4G2, MCPH1]
GO:0046939;nucleotide phosphorylation;8.0;0.6729672293956388;0.7114836146978194;8.910684459341805;199.75304005510822;5.6339389012889365;0.006685554484579823;0.6631198974168686;[HK3, GPI, TPI1, ADPGK, PNKP, AK2, ALDOC, BPGM, ALDOA, NME1]
GO:0006081;cellular aldehyde metabolic process;3.0;0.5976175254657065;0.4969290753229978;7.431299675155902;27.736518612608716;5.618190544320798;9.283163167178837E-4;0.485434838299289;[RPIA, ALDH3A2, PDXK, AKR7A2, TPI1, RDH11, IDH2, PARK7, ALDH7A1, RELA]
GO:0030073;insulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;236.67564318465372;6.166155715036245;0.007921320783140251;0.711578115202808;[GAL, SNX19, PARK7]
GO:1903168;positive regulation of pyrroline-5-carboxylate reductase activity;6.0;1.0;0.8231203125901445;9.628524252492122;94.41559583685607;9.777073627680469;0.003160005024139943;0.8231203125901445;[PARK7]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[VIL1, DGKD, RPS6KA5, CAMLG, FES, ABL1, FAM83A, HBEGF]
GO:0040031;snRNA modification;9.0;0.8436909121759173;0.8180860812682478;9.481920778300246;251.95143012656578;7.9853141584524145;0.008432587624770352;0.8046099625986299;[MEPCE]
GO:0000416;positive regulation of histone H3-K36 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;9.777073627680469;0.026910571697265715;0.9324289523296623;[PAXIP1]
GO:0051292;nuclear pore complex assembly;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;123.37008173774021;7.474488534686424;0.004129085609897011;0.7053660038532718;[NUP93, AHCTF1, NUP107, NUP153]
GO:0000413;protein peptidyl-prolyl isomerization;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;156.19170532668662;6.039404009397101;0.005227595813875556;0.705096027081865;[PPIF, FKBP4, PPID]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[SCARB1, STARD13, PAXIP1, FAP, ITGB2, RAB13, ABL1, EPHB4]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ERRFI1, DOCK8, ARHGAP1, DOCK11, RGS1, ARHGDIB, EVI5L, TBC1D22A, HRAS, SEC13, TBC1D8, TBC1D2B, VAV1, ARFGAP1, BCR, DEPDC1B, SFRP1, ALS2, TBC1D20, DEPDC1, PKP4, TAX1BP3, ARHGEF1, DOCK2, EPHA1, ARHGEF5, RABGAP1, RASGRP2, RIC8A, ABR, ARHGAP21, CCL5, DVL3, NCKAP1L, CCL19, ECT2, A2M, S100A10, STARD13, CCL20, RCC2, ARHGAP25, GNAQ, RUNDC1, RAB3GAP2, SMAP1, RAB3GAP1, EZH2, LIMS1]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[VASP, CRTC2, GPX3, DCXR, ATPIF1, PKD2, ACACA, GLS, RXRA, ALDH5A1, IMPDH2, PPAT, ALDOA]
GO:0035518;histone H2A monoubiquitination;12.0;0.9326813400603323;0.9144609826203107;9.592156608321247;843.8955673342371;6.8867018697843045;0.028244425181974418;0.8003065664753022;[DDB1]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[FANCI, RNF20, PAXIP1, ANGPT1, WFS1, SPHK1, CAV1, PTPN22, UBE3A, BRCA1, COMMD1, SENP2, MASTL, UBE2L3, CDK9, FZR1, UBQLN1, TRIB3, SKP2]
GO:0032489;regulation of Cdc42 protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;50.14528765113853;7.8311634786251565;0.0016783176498546674;0.8157270763441555;[ABL1]
GO:0033690;positive regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.379178354882098;0.0021103132289136558;0.7004918368257019;[ABL1, SOX8]
GO:0006094;gluconeogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;174.6088252776196;5.926926025970411;0.005844000244301424;0.6540226378555745;[PER2, GPI, CRTC2, TPI1, G6PC3, SLC25A10, ALDOC, BPGM, ALDOA]
GO:0046826;negative regulation of protein export from nucleus;9.0;0.8436909121759173;0.8180860812682478;9.538912093802434;565.9502038013685;7.9853141584524145;0.018941843999116373;0.8046099625986299;[CDK5, PARK7]
GO:0046827;positive regulation of protein export from nucleus;9.0;0.811012628672052;0.801746939516315;9.431813958246067;516.7269860224134;6.7325511899570465;0.017294387198074676;0.740543606130341;[BAG3, TPR, CAMK1, GTSE1, EMD]
GO:0070914;UV-damage excision repair;8.0;1.0;0.875;9.628524252492122;251.03601357316452;7.292166977892469;0.008401949456549422;0.747921758369865;[DDB1, HIST3H2A, XPC]
GO:0032483;regulation of Rab protein signal transduction;9.0;1.0;0.896240625180289;9.628524252492122;48.758993290020136;8.390779266560578;0.0016319196251719597;0.8253454670833372;[MADD]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, AHCYL1, DGKD, DGKA, DEFB1, HEBP1, AKAP13, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, CCR2, PDGFRB, SPHK2, SPHK1, RHOC, VAV1, SFRP1, GAL, SPNS1, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, SUCNR1, ROCK2, IQGAP2, CRHR1, RIC8A, C3, ABR, GNG2, TBXA2R, CCL5, CCL19, ECT2, NTSR1, CCR10, SLC12A2, CCL20, CAV1, GPR55, TSHR, BAIAP3, GPR180, GNAQ, GNB2, NMUR1, CALM3, CALM1, CALM2]
GO:0008033;tRNA processing;9.0;0.6007507099811141;0.6966159801708461;8.495425787752843;356.94625997820395;4.973052582947213;0.011946670090692574;0.6505627655428052;[KARS, POP4, PUS1, RPP21, ADAT1, NAT10, SARS, TRMT1, SEPHS1, GRSF1, OSGEP]
GO:0033572;transferrin transport;10.0;1.0;0.9152410118609203;9.628524252492122;96.80640656383476;6.193554689224359;0.0032400233075819585;0.731979686697602;[TFRC, ATP6V0A2, ARHGAP1, ATP6V1F]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[MTPN, PIGT, RYK, ROM1, RORA, RUNX2, PPP1CC, SFRP1, HERC1, CDK5, CASP3, DDIT4, SOX8, ATP7A, IER2, PAFAH1B1]
GO:1903178;positive regulation of tyrosine 3-monooxygenase activity;7.0;1.0;0.8509193652572005;9.628524252492122;123.23454311126406;9.777073627680469;0.0041245492540456985;0.8509193652572005;[PARK7]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[XBP1, EGLN2, CSNK2A1, ZFAND2A, EDEM1, CAV1, ATPIF1, RAD23A, SIRT2, DDB1, ITCH, FZR1, GGA3, PSMC1, VPS11, UBQLN1, STX5, TRIB3, TRIM32, DACT1]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PYGB, GPI, SIGLEC9, ITGB2, HK3, PSMD7, ACTR1B, PSMD2, LAMP2, CTSH, GUSB, SNAP29, ACTR2, SERPINB1, FCER1G, PLAUR, COMMD3, RNASE3, TMEM173, UNC13D, SERPINB6, VAMP8, ACLY, ALDOC, DOCK2, ALDOA, SLC27A2, KPNB1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, C3, RAP1B, COMMD9, PSMB1, NCKAP1L, RAB6A, AP1M1, XRCC6, TMEM30A, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CDKN1A, CDKN2C, CDK6, CASP3]
GO:0097056;selenocysteinyl-tRNA(Sec) biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;595.208789998521;8.390779266560578;0.019921102548117044;0.8253454670833372;[SARS]
GO:0001510;RNA methylation;8.0;0.657518819034173;0.7037594095170865;8.910684459341805;188.48814991415034;5.500407508664414;0.006308528749304892;0.6562910957882058;[WTAP, MEPCE, TRMT1]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[KIF14, ARHGAP1, RASGRP4, ABR, FLCN, ARHGAP21, AKAP13, RHOT2, RHOT1, PSD4, NUP62, ARHGDIB, ABL1, ECT2, A2M, HRAS, PDGFRB, ARFGEF2, STARD13, GPR55, RHOC, ARHGAP25, VAV1, BCR, ITPKB, DEPDC1B, ALS2, MADD, KRAS, ARHGEF1, MET, ARHGEF5]
GO:0031145;anaphase-promoting complex-dependent catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.221725566191056;0.011732800519056534;0.7334203466557586;[CCNB1, FZR1, CDC26, CDC16, BUB1B, ANAPC5, ANAPC11, MAD2L1]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[PDGFRB, CD4, SFRP1, OXTR, ENDOG, PCNA, ITGA2, CASP3, EZH2]
GO:0015914;phospholipid transport;7.0;0.7763722522362496;0.7391054913753253;9.040737587590003;67.00175910617337;5.618190544320798;0.0022424885796152832;0.638233890966345;[P2RX7, SCARB1, PRELID1, TMEM30A, STARD7, PITPNB, STARD10, ABCA12]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ERRFI1, CXCL6, GPI, COPA, NCF1, EBI3, IL27, PARK7, AGER, CCL5, NPPA, IL12A, FAM3C, CCL19, CMTM7, UBE2I, CCL20, CD70, BUD31, FLT3LG, NETO2, IL6, GAL, CDK5, IL23A, CHMP6, KCNK3, HBEGF]
GO:0070911;global genome nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;6.518977089658987;0.006172937954381027;0.7296214167088868;[DDB1, XPC, GTF2H4]
GO:0090307;mitotic spindle assembly;8.0;1.0;0.875;9.628524252492122;186.05212215721153;6.193554689224359;0.006226997092562797;0.6917386748366816;[KIF3B, TUBGCP2, ZNF207, KPNB1, CLASP1, RAB11A]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[VPS18, SCARB1, GYPA, TFRC, SIVA1, ITGB3, ITGA2, CD80, NUP153, VAMP8, ITCH, CLDN9, NCAM1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[TBCCD1, WDR1, EPB41, WIPF2, LST1, ITGB2, CDC7, VRK1, VRK2, WASL, RHOC, CORO1A, VIL1, MKLN1, CFDP1, FES, TAOK2, KIT, ALDOA, CSNK1G2, CSNK1G1]
GO:1904153;negative regulation of retrograde protein transport, ER to cytosol;12.0;1.0;0.9481203125901445;9.628524252492122;2754.969419366111;7.57984905034425;0.09220634715467685;0.835754145523778;[DERL3, DERL2, UBAC2]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[RABGAP1, RCC2, TBC1D8, RUNDC1, TAX1BP3, TBC1D2B, EVI5L, ECT2, EPHA1, TBC1D22A]
GO:0030174;regulation of DNA-dependent DNA replication initiation;9.0;0.7508913569872202;0.7716863036738992;9.326243380619188;154.23465726608282;7.9853141584524145;0.005162095176516053;0.8046099625986299;[WDR18, CDK2, WRNIP1]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[XBP1, COL1A2, PCNA, CASP3, CFL1, PIK3C3, ATP7A, CRLS1, RELA, CPEB4]
GO:0046951;ketone body biosynthetic process;5.0;0.8933024483968273;0.736892236059334;9.510741216835738;171.00840773188375;7.57984905034425;0.005723497509211067;0.6778748447945537;[AACS]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[PRKCSH, SERPINA10, CCNF, MSLN, PSMD8, PSMD7, PSMD4, PSMD2, SKP2, FGA, IGFBP5, FGG, COMMD1, RABGGTA, DDB1, PSMA1, PSME2, ITIH2, GPS1, COPS7B, NEDD8, COPS7A, PSMB10, PSMA7, HSP90B1, C3, TGOLN2, PSMB5, RBBP5, UBD, PSMB1, RBBP7, APOL1, ATG5, KLHL25, WFS1, FEM1B, RHBDD1, FBXL15, FBXL16, BTBD6, RAB11A, IL6, SPSB1, COPS5, PSMC1, RAB13, STT3A, CALU, FBXL3, ASB3, KBTBD8]
GO:0043691;reverse cholesterol transport;8.0;1.0;0.875;9.628524252492122;39.64151019485986;6.943860283624253;0.001326765671179004;0.7301093378270707;[SCARB1]
GO:0035735;intraciliary transport involved in cilium assembly;8.0;1.0;0.875;9.628524252492122;77.80597868627544;6.088194173566533;0.0026040960857949586;0.6863505331661754;[KIF3B, IFT122, TNPO1, WDR34, DYNLL2, CLUAP1]
GO:0032464;positive regulation of protein homooligomerization;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;175.26005477141007;7.57984905034425;0.005865796309390097;0.7626338329336335;[HRK, BID, RHOC]
GO:0032467;positive regulation of cytokinesis;7.0;0.7043150770688792;0.7030769037916401;9.015419779605713;142.0565341908292;6.193554689224359;0.004754504356786525;0.6676580400938822;[SPAST, KIF3B, NUP62, KIF14, PKP4, KIF23, ECT2, CIT]
GO:1903181;positive regulation of dopamine biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;566.6271152709649;9.083926447120524;0.01896449961682299;0.8607930461318132;[PARK7]
GO:1903197;positive regulation of L-dopa biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;797.3961275467435;9.777073627680469;0.026688130779065896;0.896240625180289;[PARK7]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[ITCH, UBE2B, DTX3L, UBE2T, SYVN1, UBE3A, RFFL, TRIM32]
GO:1905259;negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;739.9621495532168;9.083926447120524;0.024765867222846932;0.8797934328124444;[PARK7]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[VIL1, PRNP, RER1, CIB1, RAB11A]
GO:1904046;negative regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.56108152342787;9.083926447120524;0.002160801297388009;0.7876727335416686;[SARS]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[CYFIP2, NCKAP1, OXTR, MAML1, WIPF2, PKD2L1, TIAL1, RPS6KA4, NSDHL, RPS6KA5, GNAT2, MYC, HOMER3, IL12A, EPHB4, CSNK2A1, FLT3LG, HLA-A, HLA-F, RUNX2, BCR, SFRP1, TWSG1, KARS, IL23A, DDIT4, PSME2, EPHA1, EBI3, APCDD1, CRHR1, IL22RA2, MTDH, SGPL1, TSPAN7, TSPAN4, ATP6V0A2, NCKAP1L, TSPAN2, HLA-DQA1, CCR10, BBS2, CREBBP, SIVA1, RCC2, EIF2AK3, PILRB, PILRA, SETX, COL1A2, SDC1, CALM1, HLA-DRB3, CPEB4, CDKN1A, SIGLEC9, ARPC1A, IL27, WASL, CTLA4, HRAS, CCR2, HLA-DPA1, FCER1G, CAMLG, PARP2, ROM1, PDCD1LG2, BTN3A2, GFRA2, SIRT2, VAV1, DDB1, ITPKB, KIT, TAX1BP3, HBEGF, NOTCH2NL, NEDD9, LILRA2, AKAP2, RELA, PERP, AP2S1, CCL19, BID, IL12RB1, MAP3K3, CCL20, CD70, RYK, G0S2, LILRB3, ITCH, CENPJ, HLA-DPB1, LIMS1, GALNT11, SCARB1, DGKD, NCF1, CD80, IL5RA, CIB1, RORA, IGF1R, ADORA3, NPPA, CFL1, EP300, TLE4, IFNAR2, SEMA6B, PDGFRB, LAG3, IL4R, SLC9A6, CD8B, CCNE1, MADD, ELMO1, CSNK1G2, CARD11, CSNK1G1, CD151, DIABLO, DTX2, KLHL12, ADIPOR2, CORO1A, EFNA4, AGER, RASGRP4, HSP90B1, RAP1B, NCKIPSD, FUT8, BAG3, BAG1, ABL1, DVL3, RIPK1, MARK2, ATP6V1F, FAM83A, EIF2B4, UBE2B, BTN2A1, IFT122, TNFRSF10B, TNFRSF10A, NFKB1, VIL1, NFKBIA, IL6, ARPC2, PTPRA, FES, GNAQ, CXCL6, CIITA, ITGB4, ITGB3, ITGB2, USP34, PTPN22, ITGAE, PTBP1, CASP3, NUP62, CASP2, DACT1, ACTR2, ITGA2, PLAUR, SENP2, YWHAZ, DUSP22, IRF4, LCP2, LCP1, DAGLB, MET, STOML2, ROCK2, LRP8, CLN3, GNG2, POLR2B, CCL5, MKNK2, IL21R, POLR2G, NCAM1, CSK, ANGPT1, EYA2, SHCBP1, TSHR, P2RX7, CD4, P2RX4, TNIP2, TSPAN17, CD9, CCM2, MNDA, KRAS, TEK, TNRC6A]
GO:0046726;positive regulation by virus of viral protein levels in host cell;7.0;1.0;0.8509193652572005;9.628524252492122;75.14244873640052;8.390779266560578;0.0025149501353939727;0.7800242071602487;[DDB1, TBC1D20]
GO:0002940;tRNA N2-guanine methylation;12.0;1.0;0.9481203125901445;9.628524252492122;686.9375482967295;9.083926447120524;0.022991181537835248;0.9126727335416687;[TRMT1]
GO:0002949;tRNA threonylcarbamoyladenosine modification;11.0;0.9326813400603323;0.8987696223598284;9.587702257971866;610.0652952649267;8.390779266560578;0.020418336409396956;0.8615337942327104;[OSGEP]
GO:0030035;microspike assembly;6.0;1.0;0.8231203125901445;9.628524252492122;58.56724312331254;8.390779266560578;0.001960192920240494;0.7522251544931926;[ABL1]
GO:0071901;negative regulation of protein serine/threonine kinase activity;11.0;0.7369933605727446;0.8009256326160346;9.385578073881732;1262.8536775520981;4.8942717050940985;0.0422665760931464;0.6827222349350845;[CDKN1C, DUSP5, CDKN1A, CDKN2C, CAV1, GPS1, PAQR3, CIB1, PTPN22, DUSP14, PPP2CA, DUSP22, SFRP1, CDK6, PKIA, CASP3, NUP62, STK38, ABL1]
GO:1903073;negative regulation of death-inducing signaling complex assembly;10.0;1.0;0.9152410118609203;9.628524252492122;537.9410154695624;9.777073627680469;0.01800440167228377;0.9152410118609203;[PARK7]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[NCKAP1, WDR1, EPB41, ROCK2, WIPF2, ARPC1A, WASL, CORO1A, AQP1, ABR, CFL1, ABL1, NCKAP1L, PDGFRB, PDCD6IP, KIF23, RHOC, BCR, VIL1, NISCH, MKLN1, DIAPH3, PARVG, CDK5, RAB13, TAOK2, KIT, SPECC1L, ELMO1, KRAS, DOCK2, TRIM32, ARHGEF5, PAFAH1B1]
GO:0036530;protein deglycation, methylglyoxal removal;9.0;1.0;0.896240625180289;9.628524252492122;637.3163232006199;9.777073627680469;0.02133040379007172;0.896240625180289;[PARK7]
GO:0035562;negative regulation of chromatin binding;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;31.329781184124332;7.57984905034425;0.0010485795812601483;0.6778748447945537;[FBXO18, MEPCE, SENP2]
GO:0036531;glutathione deglycation;7.0;1.0;0.8509193652572005;9.628524252492122;148.67575416318843;9.777073627680469;0.004976043692350169;0.8509193652572005;[PARK7]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[FES, NUP62, ARL2, BRCA1, CKAP5]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[P2RX7, NLRP12, NLRP7, NLRP2, NLRP3, CCL19]
GO:0090297;positive regulation of mitochondrial DNA replication;10.0;1.0;0.9152410118609203;9.628524252492122;1647.6526612288444;9.777073627680469;0.05514545178020527;0.9152410118609203;[STOML2]
GO:0000338;protein deneddylation;9.0;1.0;0.896240625180289;9.628524252492122;202.59641706362558;7.474488534686424;0.0067807197541817285;0.7784863164434164;[COPS5, TOR1A, GPS1, COPS7B, COPS7A]
GO:1901984;negative regulation of protein acetylation;9.0;0.7671156992804218;0.7797984748205;9.352270875863963;447.40598423656513;6.641579411751319;0.014974275653153575;0.7358913051622797;[SIN3A, TAF7, BRCA1, PARK7, ATG5]
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;645.2358217485536;6.7325511899570465;0.021595462279385098;0.7767319332797141;[MAP3K3, ABL1, CIB1]
GO:1902715;positive regulation of interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.8311634786251565;0.02521906460756386;0.8157270763441555;[ABL1, PTPN22, CD244]
GO:0000463;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);11.0;1.0;0.9324289523296623;9.628524252492122;360.17083382419077;7.57984905034425;0.0120545936753897;0.8200627852632958;[BOP1, RPL7L1, PES1]
GO:0000462;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);11.0;1.0;0.9324289523296623;9.628524252492122;360.17083382419077;6.221725566191056;0.0120545936753897;0.7506082871245006;[HEATR1, BYSL]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, SUV39H1, ITPR2, RORA, THBS1, AQP3, AGER, TM9SF4, HSP90B1, AQP1, NPEPPS, ALKBH5, CCNB1, MYC, FUNDC1, CASP3, NPPA, LMNA, UBQLN1, EP300, SCAP, ATP7A, CREBBP, EGLN2, ENDOG, ITGA2, CAV1, ARNT, SIRT2, SFRP1, TBL2, DDIT4, HYOU1, TEK, KCNK3]
GO:0015949;nucleobase-containing small molecule interconversion;6.0;0.7671156992804218;0.7066781622303554;9.271849308553389;109.52544358977337;6.409777797693995;0.003665718030449963;0.6509166472493662;[DUT, TXNRD1, AK2, NME1]
GO:0036526;peptidyl-cysteine deglycation;9.0;1.0;0.896240625180289;9.628524252492122;395.63041419525837;9.777073627680469;0.013241393918858872;0.896240625180289;[PARK7]
GO:0071897;DNA biosynthetic process;7.0;0.7090535922965819;0.7054461614054914;9.249034630787218;573.3007402310989;5.058574756385375;0.01918785983836615;0.609615113546532;[RFC5, POLQ, RFC3, RFC4, PCNA, RFC1, WRNIP1, SMG5, POLE4, POLB, CENPF, WRN, POLA2, NPLOC4, POLE2, POLE3]
GO:0036527;peptidyl-arginine deglycation;9.0;1.0;0.896240625180289;9.628524252492122;393.35828830974475;9.777073627680469;0.01316534791025127;0.896240625180289;[PARK7]
GO:0036528;peptidyl-lysine deglycation;9.0;1.0;0.896240625180289;9.628524252492122;394.86236570652255;9.777073627680469;0.013215688027139648;0.896240625180289;[PARK7]
GO:0036529;protein deglycation, glyoxal removal;9.0;1.0;0.896240625180289;9.628524252492122;711.5110407662346;9.777073627680469;0.02381363421608217;0.896240625180289;[PARK7]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[BCAR3, IL6, ANGPT1, CAV1, MTCP1, CAMK1, PARK7, GFRA2]
GO:1901990;regulation of mitotic cell cycle phase transition;7.0;0.6144040707577935;0.6581214006360973;8.152617732682543;36.34719157774778;3.91914047319701;0.0012165077917585339;0.551344391315166;[BTG2, CDKN1A, KIF14, BUB1B, BRCA1, PKD2, GPR132, SIN3A, CDC26, ZNF207, CASP2, EP300, KNTC1, TOPBP1, GTSE1, DACT1, NSMCE2, SENP2, TUBG1, CKAP5, SIRT2, CDC25A, DDB1, RINT1, RAD51C, TFDP1, RBL1, ESPL1, TFDP2, CTDSP2, PSME2, ANAPC5, MAPRE1, PAFAH1B1, ANKRD17, PCNA, DCTN3, MEPCE, XPC, ANAPC11, CCNB1, UBD, RAD21, TPR, CEP70, BID, CLASP1, E2F7, E2F8, FANCI, CDKN2C, RCC2, DONSON, MAD2L1BP, CNOT10, CDC7, NDC80, RAB11A, CNOT4, CENPE, CNOT6, CENPF, CDK6, CNOT7, CNOT1, PKIA, CENPJ, RFWD3, CNOT3, TAOK2, CDK2, FGFR1OP, CNOT8, EZH2, MAD2L1]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[CUEDC2, SERPINF1, RORA, AGER, NFKB1, IL22RA2, BCR, ABR, NLRP12, NLRP7, PBK, NLRP3, TEK]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[KCNK6, SLC23A2, CLIC5, SLC25A3, COX4I1, SLC35B1, ARHGAP1, ATP2A2, PKD2L1, COX6A1, PKD2, BEST3, GPR89B, AQP1, CPT2, NNT, ARL6IP5, PMPCB, CLCC1, ATP7A, SLC30A7, SLC36A1, KCND1, SLC35C2, KCNK12, CACNA2D3, ZDHHC13, ATP1B2, ATP5F1, TRPC4AP, SLC39A14, SLC5A6, COX7A2L, SLC9A6, NDUFS7, SLC25A19, VDAC3, VDAC2, SLC25A10, STOML2, SLC35D1, SLC20A1, COX15, KCNA3, ITPR2, ATP5J, ATP5I, SLC1A4, COX5B, ATP5O, CLCN3, ACACA, ATP5L, RHD, ANKH, ATP6V0A2, SLC38A6, CYC1, SLC25A20, CCL19, KCNN3, APOL1, NTSR1, ATP6V1F, TIMM8B, SLC35A2, SLC12A2, SLC37A1, ATP13A1, P2RX7, P2RX4, SFXN4, FXYD5, CALM1, KCNK3]
GO:0035791;platelet-derived growth factor receptor-beta signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.446202695698167;32.10089673219906;7.9853141584524145;0.0010743881246952718;0.8046099625986299;[PDGFRB, ABL1]
GO:1902600;proton transmembrane transport;8.0;0.7586651285174919;0.754332564258746;9.117698628726131;95.86613314633948;4.835431205071165;0.0032085532024895276;0.6222841766978864;[SLC36A1, SLC25A3, STOML2, COX15, COX4I1, ATP5J, ATP5I, COX5B, ATP5O, COX6A1, CLCN3, ATP5F1, ATP5L, COX7A2L, SLC9A6, NDUFS7, NNT, ATP6V0A2, CYC1, ATP6V1F]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, CIB1, TUBA1C, TUBA1B, KIF19, NUF2, ZNF207, FBXO5, NEFH, TUBG1, CKAP5, IQCG, EML3, NCOR1, ESPL1, KIF2C, MAPRE3, KIF20A, VAMP4, MAPRE1, KPNB1, PAFAH1B1, MCPH1, HDAC3, TUBGCP2, TUBD1, CCNB1, SPAST, KIF3B, LMNA, CLASP1, MARK2, BBS2, UBE2B, NDC80, RAB11A, NSFL1C, CENPE, CCDC88A, NIN, WEE1, SON, CDK5, FES, KIF4A, CENPJ, TBCE, FGFR1OP, CALM1, SPC25]
GO:0000466;maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);11.0;1.0;0.9324289523296623;9.628524252492122;359.4776866436308;8.390779266560578;0.012031394663048322;0.8615337942327104;[PES1]
GO:1902958;positive regulation of mitochondrial electron transport, NADH to ubiquinone;13.0;1.0;0.9625549647676366;9.628524252492122;1579.90447539753;9.083926447120524;0.05287798096983995;0.9271073857191605;[PARK7]
GO:0050847;progesterone receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;54.01143535742291;7.697632086000634;0.0018077141342769656;0.7686572628545723;[WBP2, UBE3A]
GO:0072734;cellular response to staurosporine;7.0;1.0;0.8509193652572005;9.628524252492122;359.03688486967354;8.16763571524637;0.012016641424369812;0.7686126355688037;[CASP3]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PDGFRB, PTBP1, CDCA2, PPP1R7, CALM3, PPP2R5D, CALM1, CALM2]
GO:0033365;protein localization to organelle;5.0;0.5041090598531663;0.5422955417875035;7.010086210079599;29.829169826127035;3.3522046037750814;9.983554695705216E-4;0.46167291119143417;[RPL3, NUP107, SRP54, BUB1B, IPO4, RPS15, NIPBL, IPO8, IPO9, NUP62, TMEM107, LAMP2, LONP2, TNPO1, TNPO2, ARL5A, RAB8B, GSTK1, RPS9, RPS7, COG3, PAQR3, TOMM34, GAK, NUP93, ACOX2, AGPS, CHMP4B, MAPRE3, MAPRE1, RPL29, SLC27A2, KPNB1, ACOT4, MCPH1, BECN1, TOMM40, HSD17B4, RGPD1, NCKIPSD, AP3M1, WRN, RAD21, PES1, LMNA, HEATR3, BID, RAB6A, FAM83D, RAE1, RPL19, PEX16, BBS2, TIMM8B, TMEM30A, PEX19, TOR1A, PMM1, XRCC5, AGK, RCC2, PMM2, IFT122, NUP153, RPL23A, TIMM44, RAB11A, UBAC2, SPCS2, GOLGB1, VPS41, TSPAN17, RAB3GAP2, DCP1A, RAB3GAP1, EZH2]
GO:0031060;regulation of histone methylation;9.0;0.6441938053840475;0.7183375278723128;9.027750392063192;102.09780493635188;5.587418885654044;0.003417121649160743;0.6819814868341874;[RNF20, ZNF462, PAXIP1, GFI1, ZNF407, MTF2, ZFP64, BRCA1, JARID2, SUPT6H, PHF19]
GO:0055072;iron ion homeostasis;9.0;0.811012628672052;0.801746939516315;9.292052015870908;38.23288616879122;5.395046993006588;0.0012796202927058053;0.6721435792979885;[TFRC, SLC22A17, MYC, ATP6V0A2, SFXN4, NEDD8, ACO1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, CD80, LST1, SIRPG, CIB1, COMT, PKD2, FLCN, ADORA3, RPS6KA2, MYC, CASP3, FNTB, NUP62, TRIM24, CTLA4, IL12A, JARID2, HRAS, EMD, RBM5, HAVCR2, KLF11, KLF13, IGFBP5, SERPINF1, ATPIF1, EMP3, PDCD1LG2, SIRT2, NME1, SFRP1, TWSG1, GAL, TFDP1, KARS, TAX1BP3, B4GALT7, BECN1, THBS1, STK3, TP53INP1, LMNA, CSK, E2F7, TFAP2A, ZBTB17, PRNP, CDKN2C, CAV1, IDH2, GLMN, EAF2, IFT122, PER2, ITCH, IL6, CDK6, CNOT7, FAP, TMEM115, NFIB, CD9, MNDA, CNOT8, TRIM32]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[TBX1, ABL1, JARID2]
GO:0055070;copper ion homeostasis;9.0;0.8436909121759173;0.8180860812682478;9.446202695698167;38.23288616879122;6.943860283624253;0.0012796202927058053;0.7513499630073597;[PRNP, COMMD1, ATP7A]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[PARVG, ITGB3, KIF14, ABL1, TEK, EPHA1]
GO:0033234;negative regulation of protein sumoylation;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;528.6159484410776;7.379178354882098;0.017692300070855854;0.7926125360964777;[GNL3L, PARK7, RELA]
GO:0031297;replication fork processing;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;150.6515651586252;6.375876246018314;0.005042172308252987;0.701062607729944;[CDK9, WRN, RAD51, PCNA, FBXO18, RFWD3]
GO:0032024;positive regulation of insulin secretion;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1037.3763533530775;5.514393750639154;0.03472005296862251;0.6972473647141411;[AACS, BAIAP3]
GO:0034201;response to oleic acid;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;46.1874048850311;7.9853141584524145;0.0015458508755362855;0.7314896500084853;[AACS]
GO:0010596;negative regulation of endothelial cell migration;9.0;0.8436909121759173;0.8180860812682478;9.533214072687796;299.55593944109387;5.905872616772578;0.010025867710250715;0.6982672254532021;[STARD13, TBXA2R, SERPINF1, THBS1]
GO:0010595;positive regulation of endothelial cell migration;9.0;0.8259837884571596;0.8092325194088689;9.488762310116963;298.6320589889849;5.2552850506314295;0.009994946262957053;0.664996147065328;[MAP3K3, SCARB1, GPI, ANGPT1, ROCK2, ITGB3, CIB1, THBS1, P2RX4, SP1, ABL1, TEK, MET]
GO:0015920;lipopolysaccharide transport;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;35.80744873089876;9.083926447120524;0.0011984430844115227;0.7876727335416686;[SCARB1]
GO:0032148;activation of protein kinase B activity;12.0;1.0;0.9481203125901445;9.628524252492122;1099.1709144601095;6.311337724880743;0.03678826131738048;0.770882417347765;[CCDC88A, PARK7]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[PRNP, NCF1, ANGPT1, ITGB3, CD80, LRP8, CD4, IL6, HSPH1, ARL2BP, IL23A, CCL5, KIT, ABL1, IL12A, ADNP, HBEGF]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[EIF2B4, STOML2, BTN2A1, PTPN22, BTN3A2, NFKB1, RELA, CD4, HLA-DPB1, LCP2, CSK, HLA-DRB3, HRAS, HLA-DQA1, CARD11, HLA-DPA1]
GO:2000773;negative regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.4250159730019;7.004484905440688;0.005503157311709213;0.7091290490632969;[BCL2L12, MAP3K3, CDK6, RBL1, ABL1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[ABL1, CTLA4, NCKAP1L, MNDA]
GO:0060770;negative regulation of epithelial cell proliferation involved in prostate gland development;7.0;1.0;0.8509193652572005;9.628524252492122;209.0820823569653;7.9853141584524145;0.006997789134829996;0.7592887026755414;[SERPINF1, EAF2]
GO:0007084;mitotic nuclear envelope reassembly;6.0;1.0;0.8231203125901445;9.628524252492122;35.641415366952565;7.8311634786251565;0.0011928860971405699;0.7236063770733796;[LMNA, VRK1, EMD]
GO:0007088;regulation of mitotic nuclear division;7.0;0.5860072649471136;0.6439229977307573;8.169909229792605;54.97351338155213;4.573066940603674;0.0018399140199305624;0.5847862212690335;[BECN1, CCNF, BUB1B, PKMYT1, ANAPC11, NIPBL, CCNB1, CDC26, RAD21, TPR, NUP62, ZNF207, KNTC1, FBXO5, PDGFRB, NSMCE2, MAD2L1BP, NDC80, SIRT2, NSFL1C, CENPE, CENPF, STAG1, STAG2, ESPL1, CCNE2, CCNE1, CDC16, CHMP4B, ANAPC5, CCNJL, MAD2L1]
GO:0048668;collateral sprouting;4.0;0.8653626801206646;0.6826813400603323;9.310070521373587;50.60479478960687;7.697632086000634;0.0016936969402496266;0.6436572628545723;[ABL1]
GO:0046007;negative regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;666.9675842715774;7.379178354882098;0.022322804813714202;0.7926125360964777;[PRNP, CASP3, PDCD1LG2]
GO:0048304;positive regulation of isotype switching to IgG isotypes;11.0;1.0;0.9324289523296623;9.628524252492122;1407.9016349495496;7.57984905034425;0.04712120069255247;0.8200627852632958;[PAXIP1]
GO:0061621;canonical glycolysis;15.0;1.0;0.9883613244510648;9.628524252492122;17318.20443184688;6.558197802812269;0.5796247169618144;0.8237478650742711;[HK3, GPI, TPI1, ADPGK, ALDOC, BPGM, ALDOA]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[DOCK11, CASP3, ABL1, NCKAP1L]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[EIF2B4, KIT, UBE3A]
GO:0002866;positive regulation of acute inflammatory response to antigenic stimulus;9.0;0.7866048967936545;0.7895430735771163;9.423729839846109;536.1761589628609;7.8311634786251565;0.017945333513272207;0.7967266896635242;[C3, FCER1G, PARK7]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[SETX, TBX1, SERPINF1, ZNF35, AQP1]
GO:0035646;endosome to melanosome transport;6.0;1.0;0.8231203125901445;9.628524252492122;33.20429938101479;7.474488534686424;0.0011113180183532213;0.7053660038532718;[AP1G1, AP1M1]
GO:0015937;coenzyme A biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;6508.605498321825;7.379178354882098;0.2178371686641753;0.8098004765652196;[ACOT7, DCAKD, COASY]
GO:0033344;cholesterol efflux;8.0;1.0;0.875;9.628524252492122;39.64151019485986;6.599019797332524;0.001326765671179004;0.712474179321389;[SCARB1]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CXCL6, SCARB1, GFI1, CD80, ATP2A2, PTPN22, COMT, LIAS, RELA, ABR, PABPN1, NLRP7, TBXA2R, CASP3, ABL1, NLRP3, IL12A, HAVCR2, UPF1, XBP1, ABCC2, CCL20, TNFRSF10B, TNFRSF10A, PDCD1LG2, NFKB1, BCR, P2RX7, IL6, TNIP2]
GO:0032497;detection of lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;150.00497270670016;8.390779266560578;0.005020531440782482;0.7522251544931926;[SCARB1]
GO:0071549;cellular response to dexamethasone stimulus;9.0;1.0;0.896240625180289;9.628524252492122;704.2721689024621;6.343086423195323;0.023571355689363423;0.7206263598461826;[ERRFI1, ABCC2, SERPINF1, DDIT4, AQP1]
GO:0034394;protein localization to cell surface;5.0;1.0;0.7902410118609202;9.628524252492122;29.829169826127035;6.686031174322154;9.983554695705216E-4;0.6321649570480018;[PIGU, ANGPT1, FBLN5]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[DTX3L, EPB41, CAV1, PARK7, TMEM173, STK3, PPP2CA, GNL3L, CDK5, ABL1, EP300, MAPRE3, TRIB3, MAPRE1, DACT1]
GO:0044597;daunorubicin metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.537552474286395;183.8320650030076;7.697632086000634;0.0061526937775333145;0.7445766281117727;[AKR7A2]
GO:0044598;doxorubicin metabolic process;6.0;1.0;0.8231203125901445;9.628524252492122;181.75262346132826;7.697632086000634;0.0060830967405091935;0.7167775754447168;[AKR7A2]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[BBS2, OSBPL11, SENP2, AACS, PER2, BSCL2, NIPBL, TBL1XR1, FAM120B, EP300, SDF4, SOX8, TRIM32]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[GNL3L, CAV1, TFIP11, CAMK1, ADNP, PARK7, SENP2, MET, EIF2S1, DACT1]
GO:0002322;B cell proliferation involved in immune response;7.0;1.0;0.8509193652572005;9.628524252492122;134.15586607783627;8.390779266560578;0.004490076105184324;0.7800242071602487;[ABL1]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[P2RX7, CASP3, NCKAP1L, CORO1A]
GO:2000679;positive regulation of transcription regulatory region DNA binding;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;47.96814533750694;6.641579411751319;0.0016054506559182917;0.6627709925721352;[PARK7]
GO:0000381;regulation of alternative mRNA splicing, via spliceosome;10.0;1.0;0.9152410118609203;9.628524252492122;185.80693659341267;5.649939242635378;0.00621879095239513;0.704179167478338;[PTBP1, WTAP, RBM5]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[BECN1, CALCOCO2, ITGB4, EI24, CLEC16A, PTPN22, PARK7, FNBP1L, CLN3, FUNDC1, LAMP2, VPS11, UBQLN1, ABL1, C6orf106, MARK2, ATG5, VPS18, GABARAPL1, XBP1, VTA1, PGA3, DYNLL2, PRKAB1, PGA5, SIRT2, TM9SF1, VPS41, CHMP4B, PIK3C3, CHMP6]
GO:0070886;positive regulation of calcineurin-NFAT signaling cascade;10.0;1.0;0.9152410118609203;9.628524252492122;339.2927284230194;7.004484905440688;0.011355822276687466;0.7734506956670166;[PTBP1, CIB1]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[DIABLO, EIF2AK3, TNFRSF10B, TNFRSF10A, NLRC4, HSPE1, BBC3, NLRP12, CASP3, NLRP3, CTSH, RIPK1, BID]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[RCC2, GPS1, PDE6D, TMED2, ARL2, IQGAP2, HRAS]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[NFKBIA, ITCH, NLRP12, BRMS1, ADORA3, GFI1, NLRP2, NLRP3, COMMD1, HAVCR2]
GO:0046425;regulation of JAK-STAT cascade;8.0;0.7586651285174919;0.754332564258746;9.158520623246385;46.16872612457469;4.77312732173501;0.0015452257142336023;0.6190979532066485;[PIGU, CAV1, GFRA2, IL22RA2, PPP2CA, IL6, CNOT7, ARL2BP, IL23A, CCL5, BCL3, KIT, IL12A]
GO:0000027;ribosomal large subunit assembly;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;66.59596265062147;6.280566066213989;0.002228906937441061;0.6721078059595746;[BOP1, DHX30, RPL3, WDR18, MRTO4, RPL23A, RPL3L]
GO:0002333;transitional one stage B cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;66.43488751451257;9.777073627680469;0.002223515897593707;0.896240625180289;[ABL1]
GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.811012628672052;0.8536266269261705;9.556203590912496;733.386781063286;4.956792062075433;0.024545795556936395;0.7016108891590862;[DIABLO, EIF2AK3, TNFRSF10B, TNFRSF10A, NLRC4, HSPE1, BBC3, NLRP12, MYC, CASP3, ARL6IP5, NLRP2, NLRP3, CTSH, RIPK1, BID]
GO:0045580;regulation of T cell differentiation;8.0;0.5976175254657065;0.6738087627328533;8.663443356448536;131.165971977755;4.909539177224887;0.004390007040384596;0.626074061840201;[PRELID1, XBP1, IL4R, CD80, IL27, ITPKB, IL23A, IRF4, CAMK4, ABL1, NLRP3, CTLA4, NCKAP1L, IL12A, CCL19, IL12RB1, CARD11]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[CCNF, KIF14, BUB1B, UBE3A, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, SEC13, RNF44, FBXO18, RAD23A, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CCNB1, FZR1, PSMB5, PSMB1, UBQLN1, RFFL, UBE2I, LRRC29, UBE2B, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, CDC16, FBXL3, MAD2L1]
GO:0060716;labyrinthine layer blood vessel development;5.0;1.0;0.7902410118609202;9.628524252492122;85.12843743852892;6.781341354126479;0.0028491721904478507;0.6370391240755715;[NSDHL, TMED2]
GO:0008089;anterograde axonal transport;9.0;0.8259837884571596;0.8092325194088689;9.405380701177911;71.1020239957658;6.113511981550823;0.0023797207554711163;0.7088859122241795;[RAB21, FXR1, AP3M1, SPAST, KIF3B, KIF4A, TRAK1]
GO:0034375;high-density lipoprotein particle remodeling;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;83.38206178822108;6.943860283624253;0.0027907225690680937;0.7060287030842711;[SCARB1]
GO:0009298;GDP-mannose biosynthetic process;8.0;0.8933024483968273;0.8216512241984136;9.557065288509976;615.242755880766;8.390779266560578;0.02059162135679706;0.8041048419030481;[GMPPB, PMM1, PMM2]
GO:0035461;vitamin transmembrane transport;5.0;0.7248374789738407;0.6526597513478406;8.529911963824013;27.719005021456198;7.004484905440688;9.277301525832176E-4;0.6484506956670166;[SLC5A6, SLC23A2, SCARB1, SLC25A19]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[SGPL1, PAXIP1, CAV1, GLMN, CCM2, RASIP1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ZNF175, GFI1, IKZF2, YY1, MYC, SAP130, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZBTB32, SARS, HCFC2, EID1, BRMS1, TBL1XR1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, WFS1, CAV1, NFKB1, CNOT7, CNOT1, PKIA, SP3, CDK2, NFE2L3, ZNF136, EZH2, CIITA, BTG2, TCF25, SUV39H1, OTUD7B, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, KLF11, KLF12, PEG3, RFC1, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, NFX1, MTF2, LCOR, MCPH1, HDAC3, ZNF350, HDAC1, LRP8, RELA, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, PER2, GFI1B, NFIA, NFIB, NFIC, TAF7]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[POLB, EEF1B2, ACTR2, SETDB1, TBXA2R, TP53INP1, ITPR2, SDF4, AACS]
GO:0043297;apical junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;7.697632086000634;0.001878987018571015;0.7167775754447168;[WDR1, RHOC]
GO:0034247;snoRNA splicing;10.0;1.0;0.9152410118609203;9.628524252492122;477.2673696298804;8.67846133901236;0.01597370934876576;0.8590579283277371;[RNF113A, CPSF3]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[SETX, BECN1, IL6, PCNA, PPIF, ABL1, PARK7, ECT2, RELA, EZH2, AQP1]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[IL6, RORA, TRIB3, SIRT2, ARNTL]
GO:0060736;prostate gland growth;4.0;0.8653626801206646;0.6826813400603323;9.405380701177911;43.8113314783287;7.474488534686424;0.00146632583694119;0.6322456912631272;[UBE3A]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[CIB1, PARK7, UBE2Z, IGF1R, AQP1, MYC, CFL1, SOX8, EPHB4, IER3, PDGFRB, CSNK2A1, FLT3LG, THOC6, SFRP1, CFDP1, PPIF, VDAC2, ADNP, EPHA1, PPID, CORO1A, MTDH, HSP90B1, BCL2L12, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, WFS1, NONO, RHBDD1, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, QARS, BCL3, HYOU1, MNAT1, CPEB4, AVEN, BTG2, CDKN1A, DOCK8, KIF14, BRCA1, AATF, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, HRAS, TSC22D4, FGA, DFFA, FCER1G, SPHK2, SPHK1, FGG, PLAUR, YWHAZ, DDB1, ITPKB, CREB3, PTRH2, KIT, MET, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, TBX1, ANGPT1, EYA2, RYK, SYVN1, ITCH, GPAM, TNIP2, KRAS, ERCC5, PDCD1, TEK, TRIM32, MAD2L1]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[HRK, YWHAB, PARK7, UBE2Z, BBC3, FLCN, AKAP13, RPS6KA2, C1QBP, MYC, CASP3, ARL6IP5, CASP2, CTSH, CTLA4, IL12A, RBM5, PDGFRB, KLF11, DFFA, ENDOG, FBXO18, RPS7, ATPIF1, PLAUR, YWHAZ, SIRT2, VAV1, SFRP1, GAL, BRMS1, TFDP1, TFDP2, PTRH2, PPIF, ARHGEF1, ARHGEF5, ITGB3BP, PPID, DIABLO, NLRC4, THBS1, STK3, ABR, BCLAF1, CCL5, UBD, TP53INP1, TP53BP2, NLRP2, ABL1, NLRP3, RIPK1, SUDS3, ZNF622, ECT2, BID, NTSR1, TFAP2A, PRNP, PRELID1, CAV1, EIF2AK3, G0S2, TNFRSF10B, TNFRSF10A, HSPE1, EIF2S1, P2RX7, NLRP12, IL6, FAP, CDK5, MNDA, PDCD1, SERINC3]
GO:0035329;hippo signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.375876246018314;8.845336528452411E-4;0.6491829203200885;[YWHAB, CASP3, STK3, TJP2]
GO:0009060;aerobic respiration;6.0;0.7671156992804218;0.7066781622303554;8.874752450115741;31.550561209678754;5.926926025970411;0.0010559688900263317;0.6262235851885184;[CHCHD5, NDUFS8, NDUFS7, COX15, COX4I1, PMPCB, COX5B, COX6A1]
